hg_235293.1

Basic information about the TSS

---

TSS ID: hg_235293.1 Species: human Chr: chr14		Start: 68979267 End: 68979268 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000679147.1 ENST00000438964.6 AK295099 Distance: 6 GeneID: 87 HGNC/MGI_ID: HGNC:163 UniProt_ID: P12814

Gene_name: actinin alpha 1 Gene_symbol: ACTN1 Gene_synonyms: Gene_source: HGNC:163

TATA-Box annotation

---

Distance to TSS:	34385
Nearest PromoterID:	NM_001161577
Entrez ID:	23034
Nearest Unigene:	Hs.98259
Nearest Refseq:	NM_015589
Nearest Ensembl:	ENSG00000020577
Gene Name:	actinin alpha 1
Gene Alias:	SAMD4|SMAUG|SMAUG1|SMG|SMGA
Gene Description:	sterile alpha motif domain containing 4A
Gene Type:	protein-coding
CpG%:	0.005
GC%:	0.527363
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ACTN1 p2@ACTN1 p3@ACTN1 p4@ACTN1 p5@ACTN1 p6@ACTN1 p8@ACTN1 p9@ACTN1
Sample		p1@ACTN1	p2@ACTN1	p3@ACTN1	p4@ACTN1	p5@ACTN1	p6@ACTN1	p8@ACTN1	p9@ACTN1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	35.06	7.79	6.43	3.31	0.39	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	32.78	7.49	5.06	3.44	0.00	0.20	0.20	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	33.18	8.68	6.37	2.12	0.19	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	33.47	8.11	4.99	3.74	0.42	0.00	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	32.17	8.32	5.17	4.27	0.00	0.00	0.22	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	31.20	7.56	4.07	4.07	0.00	0.00	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	39.87	8.93	4.14	4.36	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	39.24	5.09	3.39	2.91	0.24	0.00	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	43.60	6.63	3.85	4.92	0.21	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	26.08	6.96	1.16	4.06	0.58	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	23.45	7.68	3.64	2.02	0.40	0.00	0.81	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	30.90	4.07	2.03	4.47	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	289.34	82.05	48.84	19.50	1.45	0.32	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	218.31	66.61	29.77	13.98	0.90	0.45	0.60	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	261.71	75.09	37.98	19.76	1.10	0.44	0.22	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	238.41	73.69	37.72	19.62	3.02	0.25	1.01	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	212.73	70.11	31.67	13.10	0.44	0.66	0.22	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	218.50	73.82	38.39	19.40	0.00	0.00	0.42	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	222.86	62.38	42.65	13.86	1.60	1.07	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	250.18	74.17	31.59	13.24	1.20	0.15	1.05	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	231.75	68.56	39.29	16.31	0.53	0.53	0.27	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	255.83	63.18	32.11	15.19	1.38	0.00	0.69	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	218.19	66.96	41.23	11.12	0.78	0.13	0.78	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	215.73	61.88	33.49	13.83	0.73	0.24	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	285.34	78.17	42.31	12.13	1.81	0.00	0.26	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	240.23	67.73	29.75	15.51	0.63	0.32	0.32	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	249.45	76.37	35.71	21.43	0.55	0.55	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	304.83	83.22	45.26	21.69	0.94	0.47	0.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	238.09	72.20	33.60	17.93	0.65	0.32	0.81	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	251.90	66.60	43.97	15.02	0.72	0.54	0.36	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	229.23	66.57	39.78	14.24	1.05	0.63	0.84	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	278.61	71.51	40.25	18.17	0.20	0.39	0.59	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	257.67	75.55	35.45	17.30	1.06	0.63	0.63	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	232.73	63.01	30.18	14.84	0.82	0.33	1.48	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	278.43	75.17	43.38	16.46	0.56	0.00	0.93	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	271.53	83.36	49.44	18.20	0.77	0.38	1.15	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	250.98	68.67	35.97	16.96	0.61	0.00	0.20	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	234.93	63.47	35.06	17.53	0.60	0.81	0.40	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	253.90	80.22	50.24	23.23	1.08	0.54	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	275.11	82.10	39.85	17.76	0.96	0.00	0.72	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	261.84	69.87	39.29	16.47	1.18	0.24	0.24	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	258.39	72.90	33.09	17.42	1.32	0.59	0.59	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	275.43	95.96	43.65	16.24	0.21	0.21	1.05	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	322.21	91.96	46.85	18.36	1.57	0.35	0.52	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	334.69	95.37	52.60	18.87	2.01	0.20	1.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	334.78	93.29	46.76	18.15	1.86	0.23	0.70	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	303.48	85.89	44.14	22.31	0.96	0.48	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	314.44	89.71	45.90	18.48	2.09	0.60	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	303.53	81.39	44.04	20.59	1.20	0.72	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	339.69	85.73	55.40	19.01	0.81	0.61	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	348.42	102.27	56.36	20.91	1.64	0.41	1.02	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	405.39	114.97	63.38	24.02	0.89	0.00	1.11	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	321.82	139.92	13.99	0.00	0.00	0.00	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	246.63	63.87	37.61	15.97	1.77	0.35	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	230.31	59.98	26.18	17.23	1.33	0.66	0.66	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	211.41	67.11	26.85	15.10	0.00	2.52	3.36	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	225.03	66.13	34.44	12.86	1.38	0.00	1.38	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	270.95	73.90	45.05	22.36	1.62	0.32	1.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	267.86	63.27	35.33	20.55	0.96	0.64	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	345.13	95.87	49.04	19.17	0.94	0.31	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	325.03	74.03	29.61	26.79	0.71	0.71	1.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	296.10	66.73	29.72	17.38	1.12	0.00	2.24	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	822.42	225.31	107.48	43.79	2.39	1.59	2.39	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	554.84	140.32	64.22	25.82	1.02	0.00	0.68	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	430.52	138.74	70.83	24.04	1.30	1.30	0.32	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	474.61	108.27	60.70	22.01	5.32	0.00	1.77	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	711.21	161.64	80.82	16.16	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	758.16	165.85	126.36	31.59	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	680.08	124.32	48.75	37.54	3.41	0.49	3.41	4.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	694.22	132.89	49.09	27.27	0.99	0.00	1.49	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	647.85	106.96	37.53	35.18	1.88	0.00	2.35	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	694.17	166.59	60.28	22.85	0.99	0.00	0.99	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	528.66	121.88	34.34	25.06	4.33	0.31	3.71	2.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	565.02	114.04	36.38	26.91	1.83	0.31	1.83	1.83
Adipocyte - breast, donor1	11376-118A8	203.21	41.18	21.07	14.57	1.11	0.32	0.16	0.48
Adipocyte - breast, donor2	11327-117E4	239.84	48.29	28.24	15.24	2.89	0.00	3.37	2.73
Adipocyte - omental, donor1	11473-119C6	232.70	52.04	25.19	12.34	1.15	1.40	0.51	0.64
Adipocyte - omental, donor2	11474-119C7	227.24	38.87	27.66	14.95	1.49	0.00	0.75	1.49
Adipocyte - omental, donor3	11475-119C8	174.49	29.81	26.12	13.06	1.34	1.67	1.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	197.14	33.81	33.81	12.76	0.00	0.64	1.28	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	238.59	34.08	28.59	7.70	0.00	0.00	0.00	4.40
Adipocyte - subcutaneous, donor2	11336-117F4	83.10	17.16	9.03	9.94	0.90	0.45	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	61.34	11.30	11.64	5.56	0.17	0.52	0.35	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	173.08	34.03	14.08	12.91	0.59	0.59	0.39	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	154.43	27.80	17.24	21.88	0.00	1.03	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	181.20	34.01	16.45	22.58	0.28	0.28	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	97.58	14.11	11.17	21.16	0.59	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	224.89	38.53	16.17	10.13	0.16	0.97	0.16	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	210.11	41.64	18.40	20.66	0.00	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	164.22	26.66	20.79	13.33	0.00	0.00	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	176.95	28.93	18.36	15.02	0.00	0.56	1.11	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	283.22	46.58	28.70	17.88	1.25	1.66	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	208.47	34.91	16.33	13.31	0.00	0.00	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	200.93	29.45	15.05	17.67	0.33	0.65	0.98	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	263.67	38.97	27.10	14.61	0.00	0.00	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	425.20	70.72	30.72	57.90	2.21	0.44	0.44	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	283.28	24.38	26.18	35.50	1.08	0.36	1.08	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	239.60	47.92	16.77	20.37	1.20	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	404.97	58.83	33.64	36.70	1.80	0.54	0.36	1.62
Amniotic Epithelial Cells, donor2	11613-122A2	209.19	45.18	43.51	23.43	0.00	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	508.89	84.85	51.36	29.79	1.03	0.62	0.82	1.23
Anulus Pulposus Cell, donor1	11248-116E6	38.56	10.18	6.98	9.04	0.57	1.26	0.23	0.11
Anulus Pulposus Cell, donor2	11463-119B5	37.23	9.31	7.10	8.82	0.00	0.98	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	205.78	34.60	23.81	8.99	0.45	0.00	2.25	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	212.73	39.94	33.43	14.76	1.30	0.43	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	192.62	55.65	29.96	14.98	2.14	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	173.67	35.87	26.01	12.85	0.90	0.30	2.09	1.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	160.61	44.26	29.09	21.50	0.00	1.26	5.06	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	187.46	44.22	23.76	7.92	0.00	2.64	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	179.34	37.04	23.72	9.42	1.30	0.65	1.95	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	206.31	39.81	32.04	14.56	1.46	0.49	0.97	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	188.26	51.07	22.57	7.13	1.19	0.59	1.78	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	194.72	41.43	26.36	12.81	1.51	0.75	1.13	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	176.34	41.36	26.85	9.43	2.18	0.73	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	180.54	45.14	16.30	3.76	1.25	1.25	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	166.71	43.00	21.09	9.39	0.66	0.33	0.82	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	171.96	31.39	13.65	12.28	0.00	0.00	4.09	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	139.33	37.85	19.15	7.69	0.45	0.75	0.90	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	203.06	40.18	26.79	11.25	2.68	0.00	3.21	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	222.76	51.20	31.55	11.53	1.13	0.94	0.57	1.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	232.00	60.94	28.33	14.70	1.60	0.80	0.53	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	197.04	36.09	17.56	11.71	2.93	4.88	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	219.76	46.94	30.35	10.12	1.66	1.00	0.66	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	199.32	28.82	25.22	16.81	0.00	0.00	2.40	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	169.93	28.32	14.16	3.54	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	201.38	47.34	29.33	10.63	0.69	1.37	1.72	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	171.99	41.95	12.58	16.78	0.00	0.00	4.19	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	223.30	39.32	31.07	13.11	1.94	1.46	1.94	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	240.95	51.61	31.11	12.52	2.28	0.38	1.14	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	207.14	60.57	24.23	8.48	1.21	0.00	3.63	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	216.61	31.92	26.79	11.97	1.14	0.00	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	201.38	43.82	30.36	9.83	0.43	0.86	1.28	1.50
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	193.31	50.07	30.45	11.10	1.03	0.26	2.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	198.47	45.04	26.74	15.01	0.47	0.00	2.82	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	206.43	35.37	33.12	9.65	1.29	0.32	0.96	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	191.92	49.94	28.54	11.42	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	174.90	36.27	23.98	17.55	1.17	0.00	1.17	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	214.36	40.04	29.20	11.74	1.20	0.60	1.20	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	209.09	46.33	34.45	8.32	1.19	0.00	2.38	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	219.19	36.11	30.01	12.71	1.02	0.00	2.03	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	225.91	44.57	29.29	14.01	1.02	0.76	1.78	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	165.83	37.49	27.32	6.99	0.00	0.64	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	209.73	47.90	25.46	11.22	0.43	0.00	1.29	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	212.74	39.80	28.37	12.91	0.64	0.21	1.48	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	185.30	43.79	24.07	9.28	1.74	0.58	0.58	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	233.35	45.35	25.51	15.12	1.89	0.94	3.78	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	199.02	44.08	24.92	7.63	0.51	0.68	1.02	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	217.74	48.64	18.53	11.58	2.32	0.00	4.63	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	207.03	29.58	12.68	10.56	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	221.92	41.60	29.80	10.72	1.50	0.64	1.07	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	216.60	52.34	21.66	4.81	0.60	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	154.54	34.99	16.04	8.75	0.73	0.00	1.46	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	189.42	39.08	27.82	12.18	0.92	0.46	3.22	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	247.38	66.31	22.95	2.55	2.55	2.55	2.55	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	157.88	37.63	20.08	8.90	0.51	1.02	0.51	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	217.59	48.31	33.24	12.80	1.86	1.03	1.24	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	208.08	53.55	26.62	11.32	0.61	0.00	1.22	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	184.99	37.28	31.07	11.95	1.43	1.43	4.78	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	194.02	47.01	30.60	11.31	2.00	0.89	1.55	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	128.17	33.57	24.41	6.10	1.53	0.00	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	181.68	30.46	18.28	9.97	1.11	0.00	1.66	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	209.72	51.11	32.04	11.65	0.26	0.53	0.79	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	172.64	41.07	26.53	11.27	1.45	0.73	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	296.97	58.83	29.11	27.39	2.21	2.09	0.98	0.37
Astrocyte - cerebellum, donor2	11580-120F5	334.10	72.57	37.48	35.60	2.23	0.34	0.86	0.51
Astrocyte - cerebellum, donor3	11661-122F5	299.10	86.84	41.32	16.99	1.05	0.42	0.42	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	265.27	80.17	31.37	16.38	2.44	3.49	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	285.69	82.67	34.62	20.38	2.59	0.16	0.97	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	555.62	127.68	46.54	32.07	1.64	0.45	0.89	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	38.76	5.62	2.52	20.87	0.23	0.34	0.34	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	43.22	5.89	2.26	24.43	0.88	0.00	0.25	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	42.45	4.10	2.84	20.03	1.02	0.46	0.23	0.00
Basophils, donor1	12241-129G9	46.29	14.91	13.08	7.58	0.00	0.26	0.00	0.00
Basophils, donor2	12242-129H1	38.24	13.71	8.30	4.69	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	44.83	13.08	6.76	6.17	0.29	0.00	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	230.48	38.38	25.87	17.46	0.86	0.86	1.08	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	287.57	34.75	19.20	36.57	2.29	0.00	1.37	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	208.03	7.17	0.00	14.35	0.00	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	256.71	31.38	20.08	18.20	0.00	0.00	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	513.01	63.84	40.13	37.43	0.83	0.42	0.21	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	211.87	27.87	23.49	22.57	1.38	0.69	0.92	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	147.38	20.51	11.52	16.91	0.90	0.18	0.18	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	45.09	8.63	2.24	13.43	0.00	0.64	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	67.06	27.05	12.96	10.14	0.00	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	76.84	30.07	20.42	13.18	0.00	0.37	0.74	0.00
CD14+ Monocytes, donor3	11381-118B4	76.40	20.20	17.34	13.17	0.22	1.10	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	17.55	4.25	3.40	9.34	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	21.61	5.31	2.27	8.72	0.00	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	19.40	6.25	1.97	14.46	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	160.74	34.69	19.23	14.60	0.87	0.87	0.72	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	189.49	38.92	18.71	19.31	0.30	0.60	0.60	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	216.99	46.90	28.90	16.35	0.47	0.00	0.47	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	145.97	30.63	14.06	14.73	0.67	0.00	0.33	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	212.25	40.02	17.94	15.46	1.38	0.55	0.28	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	199.33	42.40	19.09	12.89	0.74	0.25	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	134.91	27.61	12.73	10.18	0.78	0.39	0.20	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	174.31	36.68	17.63	10.86	1.07	0.36	0.18	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	149.51	29.82	13.06	13.28	0.22	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	119.40	31.84	10.77	10.30	0.70	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	184.28	38.55	17.95	12.14	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	147.54	31.06	15.53	6.66	0.00	2.22	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	143.84	29.90	19.34	10.56	0.30	0.45	0.74	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	164.43	35.92	21.75	14.37	0.60	0.60	0.80	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	154.48	28.52	13.12	10.20	0.62	0.42	0.62	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	151.23	41.41	17.39	14.41	0.23	0.23	0.69	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	187.30	36.87	15.38	12.67	0.23	0.45	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	174.15	30.99	18.33	16.15	0.87	0.44	0.44	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	116.74	30.66	16.14	13.45	1.08	0.00	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	155.10	38.56	17.62	15.00	1.05	0.35	0.52	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	172.12	41.66	18.10	18.10	0.84	0.00	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	103.25	27.74	13.59	16.17	0.73	0.55	0.18	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	216.64	48.96	16.91	20.78	0.35	0.00	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	225.50	39.05	21.94	21.94	0.00	0.00	0.88	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	151.71	31.21	12.90	10.46	0.17	0.17	0.70	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	147.93	26.39	15.61	11.89	1.12	0.74	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	179.34	35.57	10.56	12.07	0.43	0.43	0.22	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	99.10	24.98	13.51	9.83	0.41	0.41	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	166.20	32.22	11.13	13.21	0.00	0.00	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	143.60	34.10	11.37	9.74	0.00	0.23	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	11.99	5.23	1.74	4.58	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	13.17	4.16	2.77	5.77	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	12.13	3.25	1.30	5.63	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	69.30	24.76	10.43	17.75	0.16	0.31	0.16	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	47.85	15.19	9.95	15.37	0.17	0.17	0.52	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	63.77	18.51	9.59	30.55	0.22	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	6.63	2.30	1.02	3.57	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	2.85	2.20	1.10	1.10	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	3.16	1.05	0.84	1.26	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	6.10	0.00	2.03	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	5.42	1.36	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	1.04	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	5.33	1.60	1.07	1.60	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.00	0.00	0.54	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	2.81	1.40	0.70	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	1.57	1.57	0.00	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1.32	1.32	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.00	1.64	0.82	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	2.18	1.45	1.45	0.73	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	0.00	0.00	0.50	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	14.55	2.42	3.64	2.83	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	5.99	0.80	2.00	1.20	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	20.08	4.02	10.04	4.02	0.00	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	15.17	4.49	3.37	6.18	0.00	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	55.99	10.90	5.26	13.15	0.00	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	54.79	12.18	6.31	15.78	0.23	0.90	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	51.06	12.85	7.14	19.64	0.00	5.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	33.68	9.19	7.35	12.25	0.61	1.22	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	19.52	6.71	5.18	10.67	0.00	0.61	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	51.05	13.53	12.00	23.74	0.00	0.26	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	68.73	10.56	13.70	26.73	0.00	0.00	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	79.05	15.52	16.96	32.48	0.29	1.44	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	63.05	16.59	17.54	24.65	0.00	3.32	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	75.15	25.99	19.67	23.18	0.00	4.92	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	62.63	9.89	16.48	29.67	0.00	19.78	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	8.38	1.16	1.30	4.05	0.14	0.14	0.14	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	15.08	2.54	3.22	9.66	0.00	0.34	0.34	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	16.28	4.03	3.39	11.28	0.16	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	4.48	0.90	1.34	1.79	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	6.99	2.10	2.10	2.10	0.00	0.00	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	7.48	2.20	3.08	3.08	0.00	0.44	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	11.81	4.22	3.37	10.12	0.00	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	14.54	3.53	3.32	9.35	0.21	0.00	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	12.70	6.01	3.68	10.02	0.00	0.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	171.05	25.83	12.51	54.11	0.27	2.72	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	179.54	26.80	23.05	43.95	0.00	4.82	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	148.84	23.31	23.31	39.45	0.00	8.97	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	10.20	3.89	2.97	7.23	0.00	0.19	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	4.55	0.87	1.08	1.52	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	4.41	1.05	1.47	2.31	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	27.30	8.09	4.04	15.17	0.00	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	22.10	3.47	6.07	8.67	0.00	1.30	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	35.30	10.02	6.54	12.20	0.00	2.61	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	80.17	15.84	7.92	17.32	0.00	2.97	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	52.62	7.39	6.46	10.16	0.00	3.69	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	46.06	9.77	2.79	13.96	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	62.59	10.80	6.37	27.42	0.28	1.38	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	71.41	9.57	6.63	30.92	0.25	2.70	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	46.20	13.86	6.16	15.40	0.00	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	56.22	14.68	6.09	18.62	0.00	2.15	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	33.24	6.92	4.15	12.46	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	24.23	3.93	0.98	7.86	0.65	0.65	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	6.01	0.75	1.13	1.50	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	66.66	13.13	8.33	15.91	0.00	4.04	0.50	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	49.55	6.88	3.67	11.01	0.00	0.00	0.46	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	45.05	9.83	1.92	11.98	0.00	0.00	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	39.94	8.48	1.92	9.30	0.27	0.27	0.27	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	42.03	6.00	2.70	11.11	0.00	0.90	0.30	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	42.00	7.20	3.60	9.36	0.24	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	53.44	7.96	1.59	10.00	0.00	0.00	0.23	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	47.80	9.34	3.69	13.91	0.00	0.22	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	58.43	10.53	3.95	13.42	0.26	0.00	0.53	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	57.93	10.08	2.81	16.18	0.00	0.23	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	45.58	7.25	3.92	13.58	0.30	0.00	0.60	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	47.06	13.36	6.10	11.04	0.29	0.00	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	48.49	6.13	4.26	13.32	0.27	0.27	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	60.41	17.95	8.32	10.94	0.44	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	60.12	19.58	6.38	12.30	0.00	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	99.20	25.36	10.44	26.11	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	51.14	6.84	2.16	13.69	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	55.82	9.49	3.45	11.51	0.00	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	46.43	10.37	3.77	10.61	0.24	0.47	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	60.21	10.14	1.58	15.85	0.00	0.00	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	53.82	10.76	1.85	12.61	0.00	0.00	0.92	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	49.37	8.34	4.81	11.54	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	41.31	6.50	2.68	9.94	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	33.10	5.91	4.73	9.46	0.00	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	34.80	5.29	5.29	3.78	0.76	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	48.18	4.01	2.41	7.23	0.00	1.61	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	44.06	18.19	2.10	7.69	0.00	1.40	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	43.08	21.04	2.00	7.01	1.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	255.88	71.28	166.32	7.31	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	90.42	16.80	15.81	12.35	0.00	0.99	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	206.47	36.94	24.62	16.84	0.63	0.63	0.42	0.32
Chondrocyte - de diff, donor1	11261-116G1	92.21	20.45	19.76	6.93	0.00	0.35	1.73	0.69
Chondrocyte - de diff, donor2	11338-117F6	183.02	39.09	23.45	12.08	0.71	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	74.64	22.19	23.32	5.92	0.68	0.34	0.46	0.34
Chondrocyte - re diff, donor2	11339-117F7	266.79	39.39	21.49	41.18	0.90	0.90	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	152.06	33.57	25.88	16.58	0.00	0.00	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	310.08	102.71	38.44	15.26	1.15	1.61	1.03	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	397.18	137.02	58.36	16.46	1.28	0.86	1.92	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	407.97	133.81	52.04	14.69	2.04	1.68	1.42	1.24
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	99.59	29.34	10.18	12.20	0.37	1.83	0.18	0.18
Corneal Epithelial Cells, donor1	11526-119I5	331.99	44.13	27.67	40.84	1.10	0.22	0.44	0.44
Corneal Epithelial Cells, donor2	11606-120I4	104.66	21.61	12.51	7.96	0.00	0.00	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	295.25	52.15	25.31	31.70	0.51	0.51	0.51	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	254.08	64.72	13.87	12.05	0.50	0.33	0.17	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	266.84	64.66	17.03	12.62	0.63	0.00	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	203.59	37.96	6.90	10.35	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	219.33	58.21	17.71	14.79	0.86	0.54	0.22	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	3.76	1.71	0.34	0.68	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.65	0.65	0.65	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.97	0.00	0.00	0.97	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	314.86	55.87	21.85	24.85	1.00	0.17	0.50	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	298.67	49.29	34.62	25.23	0.59	0.00	1.17	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	300.61	45.25	20.64	29.41	0.28	0.28	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	447.05	86.11	58.98	25.56	0.79	0.00	1.18	1.18
Endothelial Cells - Artery, donor1	11264-116G4	322.87	41.59	29.96	19.49	0.87	0.29	1.45	0.87
Endothelial Cells - Artery, donor2	11341-117F9	234.34	36.70	24.47	20.70	2.12	0.00	0.71	0.47
Endothelial Cells - Artery, donor3	11413-118E9	287.16	46.98	25.24	21.56	1.23	0.35	0.70	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	207.69	37.24	17.07	14.85	0.66	0.44	1.11	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	289.36	41.08	17.95	16.73	0.61	0.00	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	229.47	31.29	18.61	19.45	0.28	0.56	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	119.45	18.42	11.89	15.15	0.89	0.59	0.89	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	136.93	22.39	15.10	12.50	1.04	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	162.49	29.92	18.01	15.88	0.99	0.14	0.71	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	173.65	14.00	12.00	21.61	1.60	0.40	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	288.27	38.79	24.63	19.39	2.62	0.00	2.10	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	194.82	34.42	15.78	23.86	1.12	0.25	0.25	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	246.81	43.02	16.73	28.03	0.22	0.65	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	270.51	46.41	21.86	38.71	0.12	0.49	0.37	0.49
Endothelial Cells - Vein, donor1	11267-116G7	237.74	30.71	13.65	30.71	0.00	0.00	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	223.52	33.53	19.56	28.64	0.70	1.40	0.00	1.40
Endothelial Cells - Vein, donor3	11416-118F3	213.22	38.94	24.49	17.74	0.31	0.31	0.63	0.31
Eosinophils, donor1	12244-129H3	106.73	15.25	30.49	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	704.66	226.09	64.36	64.36	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	506.49	160.51	57.07	46.37	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	327.64	44.22	23.70	37.87	0.73	0.00	0.49	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	147.69	27.04	18.72	20.80	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	325.38	48.81	16.27	48.81	0.00	0.00	16.27	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	344.83	108.38	55.01	14.37	1.64	0.82	2.05	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	74.78	19.38	18.28	6.35	1.09	0.11	0.88	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	77.14	23.62	18.20	8.99	0.76	0.11	0.43	1.30
Fibroblast - Aortic Adventitial, donor1	11245-116E3	250.93	55.30	30.20	16.86	1.46	0.00	0.97	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	318.80	79.70	44.35	18.70	1.09	0.68	0.55	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	217.48	51.15	45.14	12.66	1.58	0.74	1.05	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	231.61	31.09	25.30	33.99	2.37	1.05	1.58	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	131.55	33.22	19.93	10.63	0.33	0.00	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	433.67	77.12	68.50	19.96	1.36	0.91	1.81	2.27
Fibroblast - Cardiac, donor2	11345-117G4	823.13	143.25	68.22	34.87	2.27	1.52	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	305.97	70.97	33.44	14.35	2.52	0.16	1.42	2.05
Fibroblast - Cardiac, donor4	11452-119A3	147.92	23.95	19.40	18.49	0.00	0.61	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	213.96	37.94	23.22	17.89	0.89	0.63	0.00	0.25
Fibroblast - Cardiac, donor6	11460-119B2	198.74	25.01	18.34	21.53	0.61	0.00	0.61	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	142.16	35.78	26.40	9.51	0.94	1.34	0.40	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	130.72	39.69	34.08	6.90	1.29	1.29	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	423.33	76.17	33.69	30.76	7.32	0.00	4.39	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	291.76	52.82	26.75	48.20	0.92	3.92	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	41.89	15.94	12.89	5.94	0.68	3.39	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	84.99	17.84	13.62	15.26	0.47	0.00	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	183.01	23.58	13.21	30.66	0.00	0.47	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	80.03	21.40	12.57	10.15	0.60	0.60	0.48	0.36
Fibroblast - Dermal, donor4	11450-119A1	129.44	22.27	12.43	25.32	0.79	0.68	0.23	0.23
Fibroblast - Dermal, donor5	11454-119A5	137.64	24.25	11.86	29.48	0.35	0.00	0.52	0.35
Fibroblast - Dermal, donor6	11458-119A9	145.37	23.39	10.72	27.61	0.00	0.49	0.81	0.32
Fibroblast - Gingival, donor1	11237-116D4	120.36	33.73	17.49	13.33	0.62	0.00	0.00	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	382.78	87.51	42.71	32.49	0.52	0.26	1.31	1.31
Fibroblast - Gingival, donor2	11318-117D4	230.62	45.60	20.82	27.81	0.79	0.00	0.92	0.66
Fibroblast - Gingival, donor3	11394-118C8	96.88	29.68	19.14	15.28	0.29	0.77	0.58	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	365.69	86.23	42.59	21.82	1.04	1.04	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	349.41	75.94	36.12	26.96	1.76	0.70	1.41	1.41
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	392.08	90.73	39.13	46.61	1.09	0.78	1.25	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	348.48	85.06	37.19	32.45	1.49	0.41	1.22	0.95
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	469.33	102.34	36.35	37.76	0.00	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	448.97	109.24	45.92	44.90	1.46	0.58	0.44	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	377.56	97.63	37.36	30.13	1.50	0.82	0.82	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	652.13	134.37	49.91	55.72	0.66	0.33	0.99	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	349.97	84.52	43.29	29.64	0.73	2.35	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	182.15	17.67	21.75	24.47	1.36	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	119.37	13.43	10.45	16.41	0.00	1.49	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	128.94	27.01	13.93	15.19	1.27	0.42	0.21	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	332.38	34.15	22.49	57.48	0.00	3.33	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	232.17	34.97	29.37	26.57	1.40	1.40	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	229.50	47.86	37.78	20.43	0.56	0.56	1.96	0.00
Fibroblast - Mammary, donor1	11540-120B1	375.52	55.21	27.20	45.06	1.62	1.62	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	439.36	75.89	39.94	59.91	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	673.06	131.04	89.34	23.83	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	196.69	34.92	11.83	30.26	0.58	0.19	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	278.49	56.27	21.08	45.66	1.82	0.76	0.61	1.52
Fibroblast - Periodontal Ligament, donor3	11395-118C9	199.81	35.19	19.58	22.95	1.53	0.61	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	548.01	93.12	55.34	51.14	0.76	0.76	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	428.20	107.73	59.13	24.30	2.70	0.00	1.08	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	403.47	86.17	48.36	27.02	0.70	0.12	0.46	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	239.41	47.75	24.98	17.13	1.22	0.55	0.55	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	531.95	87.98	39.22	50.19	3.05	1.02	0.61	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	271.96	63.48	30.07	32.07	2.67	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	102.40	27.68	16.61	11.07	1.58	0.79	0.79	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	879.92	116.29	58.54	72.83	5.36	0.40	2.78	3.77
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	199.11	46.89	26.82	11.55	2.66	0.89	1.07	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	277.30	61.10	28.18	17.74	1.58	0.39	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	475.05	66.49	43.32	51.15	2.11	0.90	0.90	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	231.99	34.22	23.32	23.64	1.62	0.97	1.19	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	537.02	91.87	50.87	47.07	3.54	0.00	1.52	4.05
Fibroblast - skin normal, donor1	11553-120C5	208.71	53.65	27.57	17.06	1.97	0.33	0.49	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	442.72	107.07	34.69	44.11	3.01	0.60	0.20	1.40
Fibroblast - skin normal, donor2	11561-120D4	268.94	38.28	38.78	22.60	3.01	0.70	1.61	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	668.85	102.16	59.24	73.44	2.12	0.60	2.12	3.32
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	231.22	62.96	26.26	15.49	2.07	0.33	0.41	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	89.92	22.05	19.49	9.57	2.56	0.85	1.37	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	590.52	80.14	59.12	41.71	1.64	0.66	1.97	3.28
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	331.50	52.41	36.22	23.12	2.13	0.11	2.02	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	333.48	69.16	35.25	30.19	1.86	0.34	0.67	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	131.57	34.97	23.37	8.47	1.73	0.00	1.41	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	288.08	22.16	0.00	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	35.73	15.69	6.97	5.23	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	345.33	72.12	34.15	16.12	0.35	0.00	0.69	1.21
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	463.75	73.39	44.24	23.42	2.34	0.00	1.30	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	543.48	91.47	39.86	26.57	0.51	0.00	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	128.61	33.68	20.67	16.08	0.77	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	135.91	29.35	7.66	12.76	1.91	0.00	1.28	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	203.68	75.88	12.84	23.11	0.86	1.43	0.29	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	105.34	51.02	22.89	11.86	0.55	0.28	0.28	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	70.32	37.90	8.90	7.31	0.00	0.46	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	179.11	68.55	19.22	22.19	0.40	0.40	0.40	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	98.86	42.82	19.03	7.93	0.53	0.26	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	75.01	32.94	11.74	12.72	0.00	0.65	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	138.86	53.51	14.59	18.13	0.00	1.33	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	111.08	28.83	9.19	16.82	0.99	0.28	0.28	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	133.98	34.60	10.10	14.65	0.25	0.37	0.49	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	132.43	39.22	8.86	16.92	0.54	0.27	1.07	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	314.57	56.62	15.24	26.51	1.86	0.12	0.50	1.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	381.23	71.57	18.69	38.76	1.11	0.28	0.69	1.38
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	254.13	48.39	13.21	24.80	0.61	0.81	1.83	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	164.06	38.33	12.09	15.52	0.68	0.23	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	224.09	50.95	20.18	21.05	1.49	0.12	1.49	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	308.41	48.09	25.14	31.04	0.22	0.00	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	109.92	29.55	10.93	11.82	0.89	0.30	0.00	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	170.24	50.71	14.78	16.37	0.32	0.00	0.79	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	153.27	36.42	8.71	13.41	0.45	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	119.77	34.28	13.51	16.13	0.81	0.20	1.01	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	148.44	40.71	13.57	13.57	0.85	0.00	0.34	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	157.13	45.31	13.30	13.83	1.42	0.00	0.44	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	99.58	26.33	8.12	17.27	0.31	0.31	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	94.61	20.49	8.54	23.91	0.51	0.17	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	109.99	29.43	12.17	14.72	0.55	0.22	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	96.26	26.79	7.82	11.65	0.92	0.25	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	87.39	23.48	7.96	16.33	0.41	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	95.52	22.28	11.55	14.03	1.24	0.00	0.62	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	103.30	30.09	11.88	15.68	0.92	0.23	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	106.23	26.52	8.67	14.18	0.17	0.00	0.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	90.16	19.40	6.39	17.19	0.44	0.22	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	86.46	24.48	9.10	14.64	0.00	0.00	0.61	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	95.15	26.26	9.40	15.89	0.65	0.49	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	61.90	17.96	7.38	15.07	1.28	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	108.87	25.68	13.64	17.72	0.47	0.28	0.66	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	82.25	18.35	7.12	18.51	0.16	0.32	0.32	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	117.68	25.54	11.25	23.41	0.61	0.00	1.22	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	152.52	35.33	13.17	15.99	0.42	0.00	1.05	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	70.70	18.22	5.93	21.08	0.44	0.00	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	99.59	26.93	12.34	11.78	0.56	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	193.78	49.44	20.46	22.31	0.74	0.00	0.09	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	107.76	21.39	10.96	12.57	0.53	0.00	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	202.88	43.45	20.20	21.57	0.46	0.00	0.77	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	193.53	42.23	15.80	15.54	0.91	0.00	1.17	1.17
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	75.09	21.14	9.76	16.26	0.00	0.00	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	155.04	40.74	19.73	16.78	0.74	0.18	0.37	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	168.43	41.67	19.08	13.38	1.75	0.00	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	99.17	18.84	4.96	13.88	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	235.46	68.20	31.00	15.96	0.53	0.26	0.79	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	215.88	61.54	24.82	12.31	1.01	0.20	0.40	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	63.54	19.06	6.61	8.90	0.25	0.25	0.25	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	114.46	23.29	4.98	21.10	0.80	0.40	1.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	158.70	38.36	8.63	21.57	0.62	0.46	0.62	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	174.30	54.62	14.93	22.71	0.82	0.61	1.02	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	64.46	27.85	4.69	6.88	0.00	0.31	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	71.49	22.04	7.35	8.76	0.85	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	95.01	21.68	11.53	12.91	0.00	0.46	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	118.79	29.70	14.85	22.27	2.47	0.00	0.00	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	126.87	26.69	16.25	10.06	1.55	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	174.89	44.93	6.42	11.23	0.00	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	97.37	27.82	26.08	15.65	0.00	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	87.88	27.99	11.39	8.14	0.98	0.65	0.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	106.66	23.88	11.12	10.71	0.00	1.24	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	86.64	36.65	19.99	16.66	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	73.27	22.09	11.19	8.39	0.56	0.56	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	86.94	26.47	11.77	10.13	0.00	0.00	1.63	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	92.27	37.75	10.90	7.55	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	88.11	17.18	10.81	10.18	0.95	0.00	0.32	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	93.07	26.15	9.51	10.53	0.68	1.02	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	123.20	20.88	8.35	12.53	0.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	63.00	23.48	9.16	11.45	1.15	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	67.48	19.53	7.40	10.95	0.30	0.00	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	76.24	22.02	13.55	13.55	1.69	0.00	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	102.31	24.44	8.70	7.46	1.24	0.41	0.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	75.02	20.48	9.21	12.20	0.69	0.69	0.69	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	73.76	21.07	0.00	10.54	0.00	0.00	5.27	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	55.36	16.53	6.92	9.61	0.00	0.00	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	59.00	10.11	7.82	6.85	0.33	0.65	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	55.51	13.38	8.69	6.69	0.00	1.34	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	47.00	13.48	3.08	9.63	0.39	1.16	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	111.95	26.36	14.72	13.35	0.68	0.00	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	77.03	19.88	9.94	4.97	0.00	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	41.52	14.63	7.08	10.85	0.94	0.00	0.94	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	51.30	10.26	7.85	17.50	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	55.45	15.26	8.14	23.40	0.51	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	40.68	11.97	7.18	13.16	0.80	0.00	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	38.98	11.84	5.92	13.32	0.49	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	59.02	18.89	7.08	9.44	0.00	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	32.67	8.17	2.92	14.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	36.43	10.53	3.95	8.34	0.44	0.44	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	51.71	11.02	3.39	11.02	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	53.13	9.55	5.97	13.13	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	37.85	9.70	3.88	7.76	0.49	0.49	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	324.13	98.15	67.34	17.12	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	235.77	104.79	46.99	9.15	2.91	0.83	0.83	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	425.04	122.57	41.60	22.49	2.25	0.00	2.25	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	103.39	30.45	26.32	7.61	1.90	1.59	0.00	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	48.88	17.96	16.29	4.60	0.42	0.42	0.84	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	75.89	19.03	10.44	8.24	1.16	0.23	0.46	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	84.06	24.14	9.62	9.96	0.51	0.51	1.01	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	85.77	17.29	8.19	6.37	0.23	0.00	0.68	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	86.68	16.83	8.64	9.73	1.09	0.11	0.77	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	91.12	25.14	9.89	12.89	0.43	0.21	1.07	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	84.61	17.22	9.47	8.40	1.08	0.00	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	72.23	18.06	6.97	7.22	0.00	0.12	0.37	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	75.31	20.07	7.38	8.41	0.69	0.17	0.69	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	74.97	16.34	9.29	7.05	0.32	0.64	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	172.92	22.94	17.35	35.26	1.68	0.00	1.12	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	689.87	109.93	63.19	46.74	4.33	0.00	1.30	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	224.72	10.58	10.58	15.86	0.00	0.00	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	326.62	46.21	46.21	30.33	0.00	1.41	0.00	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	374.88	66.84	57.39	18.89	2.18	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	125.36	16.96	16.43	15.56	1.22	0.00	0.87	0.35
Hepatocyte, donor1	11523-119I2	56.90	15.74	20.58	4.84	0.00	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	112.04	32.32	21.55	10.77	1.08	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	131.30	25.77	19.02	9.82	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	5.87	1.31	1.31	6.53	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	70.79	28.49	6.29	11.54	0.52	0.17	0.35	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	193.74	53.37	27.44	14.96	1.37	0.69	0.27	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	19.10	6.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	13.35	6.68	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	6.92	13.84	8.31	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	5.01	7.51	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	11.87	23.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	12.81	12.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	4.57	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	4.87	19.49	9.75	3.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	11.67	6.67	15.01	3.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	14.52	18.15	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	11.91	25.15	7.94	1.32	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	9.98	7.76	9.98	2.22	0.00	0.00	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	15.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	9.45	11.34	9.45	1.89	0.63	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	6.19	18.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	29.27	29.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	13.57	22.61	14.21	1.29	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	8.05	12.88	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	23.90	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	17.93	22.82	10.59	0.00	1.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	9.66	12.17	9.24	1.68	0.00	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	12.06	20.09	12.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	7.39	3.69	12.93	1.85	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	10.38	16.52	16.52	1.42	0.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	5.44	8.16	11.79	0.91	0.00	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	15.07	26.90	15.07	1.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	15.25	11.43	1.27	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	16.43	32.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	9.57	19.77	13.39	2.55	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	9.11	10.94	20.05	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	15.00	21.42	9.28	1.43	0.00	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	9.95	6.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	8.95	14.20	13.27	1.23	0.00	0.62	0.93	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	10.54	7.02	12.29	3.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	6.29	12.57	6.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	10.43	20.86	11.13	0.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	6.64	8.85	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	3.24	12.97	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.10	16.57	8.72	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	4.50	15.75	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	20.91	3.48	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	11.73	20.27	10.67	2.13	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	13.85	15.24	9.70	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	14.25	2.85	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	8.28	23.93	11.05	1.84	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	12.10	9.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	18.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	3.17	15.86	11.63	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	456.96	89.68	42.51	24.15	4.16	0.41	1.39	0.82
Keratinocyte - epidermal, donor2	11349-117G8	256.51	38.07	21.08	20.50	3.51	0.00	4.10	0.00
Keratinocyte - epidermal, donor3	11421-118F8	417.24	74.87	30.10	30.57	2.37	0.19	1.14	1.14
Keratinocyte - oral, donor1	11251-116E9	304.23	63.00	37.57	30.42	2.38	0.57	1.36	1.25
Keratocytes, donor1	11527-119I6	273.35	52.61	29.91	38.51	0.69	1.72	0.34	0.69
Keratocytes, donor2	11607-120I5	140.62	46.87	23.44	32.81	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	123.30	39.72	28.45	17.59	0.20	2.17	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	514.31	76.93	52.75	48.35	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	270.76	66.88	42.07	15.10	3.24	2.16	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	90.65	32.18	11.65	6.34	0.46	1.15	0.00	0.23
Lens Epithelial Cells, donor3	11690-122I7	569.63	138.95	59.74	25.03	1.01	1.11	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	201.94	34.03	14.70	17.08	1.78	0.00	0.83	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	125.58	24.84	8.09	9.21	0.00	0.00	0.56	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	186.69	30.54	15.43	14.32	1.57	0.47	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	168.84	28.50	10.22	15.59	1.61	0.54	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	227.86	39.08	13.24	19.86	0.32	0.00	0.63	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	159.67	24.91	11.21	12.18	1.29	0.65	0.65	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	157.18	24.21	12.31	15.59	0.82	0.00	1.64	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	132.48	27.56	9.35	11.63	0.76	0.00	0.76	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	160.60	26.88	14.36	10.70	0.99	0.42	1.13	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	122.62	19.38	11.87	12.66	0.00	0.00	0.00	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	131.45	32.57	9.89	11.83	0.58	0.19	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	153.49	26.11	10.74	13.15	0.56	0.37	0.56	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	145.64	26.83	14.63	9.76	0.70	0.35	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	145.02	27.91	10.26	13.12	0.72	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	159.19	28.57	13.05	15.25	0.82	0.55	1.51	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	141.97	23.71	14.17	9.85	0.92	0.00	0.31	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	115.35	20.26	7.17	13.72	0.31	0.00	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	195.98	31.47	13.91	18.67	1.10	0.37	1.28	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	169.82	24.03	12.51	14.81	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	139.99	25.19	9.96	10.54	1.17	0.00	0.88	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	183.71	28.38	13.69	12.94	1.24	0.50	1.24	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	153.73	24.73	12.61	17.46	1.45	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	115.80	26.39	10.50	9.16	0.81	0.00	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	176.66	31.03	11.66	13.17	1.21	0.76	1.97	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	139.45	19.70	13.48	8.81	1.04	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	122.28	25.34	11.73	10.05	1.05	0.00	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	190.22	33.08	14.13	12.63	1.20	0.45	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	130.70	21.32	15.13	14.45	0.00	0.00	1.38	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	115.90	21.45	12.04	10.54	0.56	0.00	0.19	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	168.80	30.01	14.42	11.88	1.48	0.64	1.06	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	137.62	24.71	12.60	11.15	0.48	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	105.19	26.79	6.28	7.61	0.33	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	169.36	27.88	12.27	13.38	1.24	0.99	0.62	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	189.18	35.17	22.58	15.18	0.37	0.00	1.11	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	104.76	19.77	8.40	7.66	0.74	0.25	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	152.89	25.85	12.65	12.65	1.51	0.14	0.96	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	166.93	30.23	11.26	11.26	0.64	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	126.91	27.69	11.87	9.74	0.91	0.00	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	174.40	29.53	13.72	14.28	0.56	0.14	0.70	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	142.58	26.31	13.51	9.96	0.71	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	87.26	18.91	8.73	3.39	0.00	0.48	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	174.13	27.54	11.83	13.85	2.02	0.31	0.93	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	144.32	23.99	17.19	11.10	0.72	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	133.61	30.05	13.39	9.15	1.31	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	163.38	26.37	13.65	15.07	1.41	0.00	1.88	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	183.77	30.57	16.09	12.99	1.86	0.25	0.50	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	100.66	19.21	10.50	9.73	1.28	0.00	0.26	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	167.38	22.38	13.43	14.92	1.49	0.00	0.30	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	67.98	24.93	0.00	13.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	84.38	26.85	10.74	13.04	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	86.10	17.81	5.94	17.07	0.00	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	79.55	33.00	8.46	13.12	0.85	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	61.89	18.29	5.63	14.77	0.00	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	65.38	14.94	5.60	14.01	0.00	0.93	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	58.74	25.25	6.18	15.46	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	88.02	17.84	11.89	13.08	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	56.10	16.06	8.37	8.37	0.23	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	68.05	20.36	7.56	13.67	0.87	0.58	0.58	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	70.23	18.91	7.20	13.96	0.90	0.90	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	81.16	27.50	8.54	15.72	0.27	0.68	0.27	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	78.06	28.76	9.76	16.43	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	76.92	21.17	8.12	16.58	0.35	0.71	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	63.30	11.99	6.66	15.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	78.45	28.53	13.24	14.77	0.00	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	80.58	21.08	10.14	19.74	0.27	0.53	0.80	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	85.78	22.11	9.64	15.87	0.38	0.38	0.76	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	76.08	20.86	9.82	15.34	1.84	0.00	1.23	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	96.22	26.09	10.60	19.57	1.63	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	90.17	28.53	11.04	16.45	0.21	0.21	0.00	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	76.23	27.75	10.09	12.61	0.84	0.28	0.28	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	81.40	18.55	6.18	13.39	2.06	0.00	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	93.48	32.80	14.22	20.90	0.58	0.87	1.45	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	82.50	22.72	9.86	13.15	0.90	0.60	0.30	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	90.18	27.66	11.62	14.38	0.55	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	120.54	38.18	14.14	18.73	0.35	0.71	0.35	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	91.83	29.13	11.06	20.28	0.00	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	64.47	25.33	14.97	16.12	1.15	0.00	0.00	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	104.00	31.08	9.21	14.97	1.92	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	73.03	25.48	10.76	17.55	0.00	1.70	1.13	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	72.20	28.72	10.67	13.95	0.82	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	96.25	27.11	8.13	18.98	1.81	0.45	0.90	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	102.69	29.44	8.62	17.95	0.72	1.44	2.15	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	110.54	24.65	11.20	21.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	92.90	31.96	11.89	15.98	1.11	0.00	1.49	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	93.90	21.97	6.89	15.51	0.00	0.86	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	74.50	29.97	8.56	20.55	0.86	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	103.62	27.65	7.00	20.99	1.00	0.33	0.33	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	88.69	28.36	10.26	18.70	1.21	0.60	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	102.38	29.15	9.95	14.22	0.71	0.00	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	105.87	26.81	9.62	11.69	2.41	0.34	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	95.54	27.91	8.05	15.57	0.00	0.00	1.07	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	90.90	20.87	10.10	14.81	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	108.90	32.60	10.74	18.89	1.11	0.74	1.85	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	98.85	23.26	4.65	18.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	84.62	22.21	14.81	13.75	1.06	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	106.84	34.41	9.60	20.01	1.20	0.40	0.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	92.31	29.80	13.08	21.81	0.00	1.45	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	114.21	29.89	12.26	16.86	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	89.78	25.16	9.87	21.70	1.48	0.99	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	126.08	35.76	6.59	16.00	0.00	2.82	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	100.56	26.15	14.08	20.11	1.01	0.50	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	122.12	32.44	11.27	15.32	0.45	1.35	0.45	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	129.08	51.63	10.33	24.10	0.00	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	120.69	40.53	7.13	20.49	0.89	0.00	0.45	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	141.16	43.79	20.72	17.60	0.39	0.00	0.78	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	132.61	35.63	13.85	22.43	0.00	3.30	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	135.44	32.17	11.42	18.68	1.04	0.52	1.04	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	137.83	33.69	12.69	24.94	1.75	0.88	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	143.69	30.75	15.65	17.89	0.56	3.35	0.00	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	165.17	39.31	10.16	15.46	0.00	0.00	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	143.49	32.01	13.11	16.20	0.39	1.16	0.77	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	138.74	34.43	13.17	18.74	0.51	1.01	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	160.05	37.97	14.42	21.15	0.96	0.96	0.48	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	146.30	38.16	7.16	18.29	0.80	0.80	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	137.32	37.67	16.41	20.05	0.00	0.00	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	113.44	15.91	15.91	15.91	0.69	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	168.34	45.98	12.54	21.66	0.38	0.38	0.38	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	139.95	35.12	14.46	20.66	0.52	1.03	1.03	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	131.81	16.93	10.28	16.93	0.00	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	141.02	43.10	12.68	21.87	2.22	1.58	0.95	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	147.67	44.25	11.19	20.26	0.00	2.13	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	113.78	20.69	6.90	16.67	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	157.36	43.20	13.88	16.46	2.06	1.03	0.00	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	155.62	45.27	18.39	24.76	0.00	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	112.36	17.02	7.94	26.10	0.00	1.70	1.13	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	117.32	32.87	11.65	20.80	0.42	1.25	1.25	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	115.89	35.24	14.09	11.75	1.57	0.78	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	105.22	18.79	9.60	18.37	0.00	0.42	0.84	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	120.34	30.20	12.55	20.44	0.46	0.93	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	146.52	34.79	4.68	18.06	0.67	0.00	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	170.02	25.66	7.48	23.52	1.07	0.53	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	153.96	39.60	8.89	20.20	1.62	0.00	1.62	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	115.64	40.38	13.77	19.27	0.92	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	128.03	22.23	11.56	23.12	1.78	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	190.91	40.46	15.96	25.07	2.28	0.57	2.28	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	166.42	41.41	5.37	14.57	1.53	0.00	2.30	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	200.81	35.57	9.85	19.70	0.55	0.00	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	190.21	52.12	14.25	26.73	0.89	0.45	1.34	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	190.03	47.31	11.44	15.60	0.78	0.78	0.52	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	226.12	35.81	16.58	17.90	0.66	1.99	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	245.28	70.67	18.71	12.47	4.16	2.08	0.00	6.24
Macrophage - monocyte derived, donor1	11232-116C8	59.26	14.81	7.07	15.95	0.23	0.23	0.00	0.68
Macrophage - monocyte derived, donor2	11313-117C8	217.09	42.94	8.26	14.86	0.37	0.37	0.37	0.37
Macrophage - monocyte derived, donor3	11389-118C3	204.09	56.36	21.76	25.30	0.13	0.92	1.05	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	204.97	41.42	22.83	8.50	1.06	1.59	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	505.46	107.27	73.84	21.23	2.85	0.32	1.74	0.16
Mallassez-derived cells, donor3	11930-125I4	447.68	75.89	51.15	29.74	2.08	0.83	1.25	0.56
Mammary Epithelial Cell, donor1	11273-116H4	287.47	55.00	25.41	19.23	1.89	0.30	0.40	0.70
Mammary Epithelial Cell, donor2	11350-117G9	283.47	52.12	23.16	20.56	2.03	0.29	1.74	0.58
Mammary Epithelial Cell, donor3	11422-118F9	549.49	85.30	41.90	41.90	2.24	0.50	0.50	1.00
Mast cell - stimulated, donor1	11487-119E2	2.03	0.00	0.68	2.03	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	1.19	0.22	0.11	0.11	0.00	0.00	0.00	0.00
Mast cell, donor2	11565-120D8	2.08	2.38	0.30	0.59	0.00	0.30	0.00	0.30
Mast cell, donor3	11566-120D9	1.80	1.13	0.90	1.58	0.00	0.00	0.23	0.00
Mast cell, donor4	11567-120E1	1.77	0.53	0.35	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	0.89	0.33	0.00	0.55	0.00	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	1.17	0.58	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	0.00	0.23	0.11	0.11	0.00	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	117.11	19.70	9.85	10.75	0.50	0.30	0.10	0.50
Melanocyte - dark, donor2	11582-120F7	84.44	15.92	14.19	11.42	0.69	1.04	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	52.88	8.55	2.46	14.78	0.22	0.07	0.22	0.07
Melanocyte - light, donor1	11274-116H5	96.85	17.40	8.46	17.63	0.71	0.24	0.47	0.94
Melanocyte - light, donor2	11351-117H1	54.60	9.55	6.14	13.65	0.68	0.00	0.68	0.68
Melanocyte - light, donor3	11423-118G1	134.42	19.08	8.67	7.81	2.60	0.00	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	137.45	21.45	7.18	18.22	0.73	0.00	0.31	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	154.10	27.16	9.14	18.02	0.81	0.54	0.81	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	46.34	9.64	4.55	9.64	0.00	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	275.78	51.36	22.95	24.81	1.98	0.12	0.74	0.37
Meningeal Cells, donor2	11573-120E7	292.26	63.38	40.05	20.25	0.88	1.32	0.00	0.44
Meningeal Cells, donor3	11654-122E7	180.28	66.59	16.63	11.00	2.85	0.49	0.65	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	111.21	19.39	9.70	14.83	0.57	0.29	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	232.26	61.69	39.95	8.35	1.11	0.70	0.60	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	99.88	11.83	11.83	10.51	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	129.51	17.01	13.08	17.01	0.00	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	204.52	38.75	29.42	22.25	0.72	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	355.56	70.31	38.12	18.42	2.12	0.85	1.06	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	356.88	78.41	44.74	24.63	3.52	0.00	2.01	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	235.14	31.20	16.70	41.53	1.10	0.88	0.22	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	320.73	48.22	20.46	36.53	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	286.65	42.97	25.78	36.62	1.02	0.61	1.02	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	101.39	21.47	12.47	11.50	0.97	2.08	0.14	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	191.81	26.02	29.74	13.38	1.12	0.74	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	178.15	56.58	34.74	11.05	1.84	1.84	0.79	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	82.49	21.07	24.63	8.31	0.30	2.37	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	105.10	23.36	28.03	11.68	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	357.34	73.65	51.23	32.66	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	166.59	33.32	20.56	13.11	0.71	1.42	0.00	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	161.99	47.85	26.27	10.32	2.19	1.25	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	177.79	26.85	18.14	17.42	0.73	0.00	0.00	2.90
Mesothelial Cells, donor1	11247-116E5	134.71	34.47	27.31	6.10	0.80	0.53	0.53	0.27
Mesothelial Cells, donor2	12156-128G5	225.71	49.05	29.03	4.50	0.00	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	209.13	52.39	33.96	11.78	2.02	0.36	0.29	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	241.71	48.61	6.75	25.66	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	221.15	49.01	17.49	18.96	0.00	0.49	0.74	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	276.20	63.01	20.91	18.85	0.88	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	231.62	86.43	13.83	31.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	115.30	29.75	9.92	11.47	0.31	0.00	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	186.27	43.98	13.28	12.65	0.62	0.83	1.24	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	226.97	53.27	23.16	27.79	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	185.94	44.05	12.76	13.51	0.25	0.25	0.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	289.06	65.63	20.48	24.20	0.00	1.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	330.92	58.40	58.40	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	154.65	37.39	14.23	14.23	0.41	0.41	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	251.44	67.31	13.86	15.84	1.19	0.40	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	367.71	128.27	51.31	25.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	100.88	19.47	6.19	7.08	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	221.50	56.23	11.78	16.34	0.38	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	189.49	56.58	18.42	9.21	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	109.72	23.56	8.28	9.76	0.21	0.42	0.85	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	283.61	72.75	17.50	21.18	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	154.99	33.38	12.22	11.33	0.30	0.00	0.89	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	347.07	103.95	25.15	28.50	0.00	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	373.44	135.80	67.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	126.96	24.84	7.78	9.79	0.25	0.25	1.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	221.98	50.39	13.78	19.01	0.71	0.48	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	204.57	57.50	14.37	14.93	0.00	0.55	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	160.48	28.78	13.81	12.66	0.46	0.46	0.23	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	256.40	59.74	14.72	18.30	0.21	0.63	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	204.85	44.23	11.41	16.10	0.41	0.41	0.61	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	132.80	26.17	11.80	12.44	0.64	0.21	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	271.42	60.91	14.00	19.78	0.22	0.44	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	237.33	51.59	20.64	0.00	0.00	0.00	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	169.08	26.94	12.26	12.70	0.66	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	324.96	81.62	17.24	18.25	1.01	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	271.75	74.56	14.91	13.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	236.19	47.29	16.31	17.67	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	306.43	74.11	17.06	21.76	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	283.48	58.88	15.26	11.99	0.00	1.09	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	148.01	25.47	13.46	15.86	0.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	286.96	59.23	16.41	15.21	0.00	0.00	1.60	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	362.00	95.99	38.39	23.31	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	195.23	33.54	10.51	8.51	0.50	0.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	350.31	107.79	0.00	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	383.24	83.58	34.65	24.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	219.84	28.46	11.82	14.89	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	392.90	87.19	30.90	17.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	333.64	64.68	24.98	24.33	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	214.20	36.94	12.40	16.86	1.49	0.50	0.50	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	283.23	54.28	24.36	22.27	0.00	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	333.69	72.93	13.26	33.15	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	150.43	26.32	10.94	10.60	1.37	0.00	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	354.91	73.08	18.82	27.13	0.00	1.75	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	272.00	61.79	20.24	23.08	0.00	1.07	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	149.81	26.37	11.50	15.15	0.28	0.28	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	308.81	61.93	16.21	22.44	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	255.83	53.61	16.90	19.23	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	167.42	26.24	12.67	13.27	0.30	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	250.02	49.25	12.94	17.53	0.42	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	267.10	72.19	7.22	64.97	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	159.77	26.78	10.16	18.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	311.88	45.53	14.80	28.46	0.00	1.71	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	158.77	33.58	8.01	20.04	0.28	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	118.43	17.62	8.29	14.25	1.04	0.78	0.52	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	278.83	44.18	15.01	36.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	161.34	28.58	8.89	27.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	140.38	18.42	8.27	15.75	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	212.82	36.52	13.77	19.76	0.00	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	90.97	18.65	4.66	14.27	0.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	105.75	13.06	3.82	11.78	0.32	0.32	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	199.02	28.75	9.95	21.67	0.22	0.44	0.44	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	146.75	21.61	12.13	17.06	0.00	0.76	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	98.30	12.78	7.95	13.35	0.28	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	151.66	20.65	7.13	16.22	0.25	0.25	0.74	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	136.85	33.24	14.99	24.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	116.14	17.94	10.58	18.23	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	153.39	20.18	11.24	21.34	0.29	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	98.50	15.25	9.89	12.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	108.99	16.97	7.44	17.27	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	7.53	0.00	7.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	55.25	1.78	3.56	10.69	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	47.97	11.83	6.90	15.44	0.33	0.99	0.99	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	94.68	12.62	9.47	13.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	40.92	11.66	3.95	11.86	0.00	0.00	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	162.98	26.08	11.18	25.15	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	74.35	15.77	9.39	15.02	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	120.12	28.23	11.19	13.58	0.27	0.80	0.27	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	25.22	6.67	3.39	10.18	0.34	0.00	0.00	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	57.46	5.89	5.89	14.00	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	50.20	10.99	5.86	16.86	0.37	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	93.34	18.67	9.33	21.78	0.00	1.56	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.24	4.28	3.21	5.34	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	15.46	3.86	11.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	71.71	10.10	3.03	15.15	0.00	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	57.76	10.96	7.17	9.28	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	6.81	6.81	2.72	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.09	0.64	1.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.05	2.43	0.00	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	9.06	3.02	3.02	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	45.68	5.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	65.25	42.41	6.52	0.00	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	0.00	4.75	9.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	50.20	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	375.50	95.87	51.70	18.31	4.09	0.86	0.65	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	272.80	100.86	52.26	16.20	1.05	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	308.38	56.74	23.36	46.72	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	436.57	56.35	25.88	25.88	0.42	0.00	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	568.33	120.93	68.26	49.25	0.19	0.38	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	671.85	84.58	87.77	81.39	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	175.43	50.32	14.28	22.44	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	305.05	101.07	45.94	29.40	0.00	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	168.25	20.51	14.23	22.18	0.42	0.00	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	279.62	46.49	31.15	23.94	0.00	0.46	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	260.50	45.67	25.40	33.51	0.27	1.08	0.00	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	186.48	37.63	24.60	25.65	0.00	0.63	0.42	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	189.29	66.81	0.00	55.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	125.08	26.31	21.34	13.40	0.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	142.91	35.73	27.34	17.32	0.27	0.27	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	163.66	29.92	20.85	13.37	0.45	0.45	0.45	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	276.31	57.32	52.58	27.11	0.00	0.33	0.00	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	176.79	35.18	23.33	19.68	0.18	0.00	0.36	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	133.14	41.90	16.97	18.03	0.53	1.59	0.00	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	170.49	31.22	21.61	21.01	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	382.98	84.67	43.32	40.37	0.33	0.98	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	256.62	37.08	33.99	20.49	0.33	0.81	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	265.46	54.68	35.98	26.10	0.18	0.53	0.35	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	139.94	58.37	16.17	18.28	0.00	0.70	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	188.94	24.82	23.45	16.55	0.92	0.46	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	213.69	32.13	22.17	15.42	0.96	0.32	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	446.97	93.46	71.74	28.97	0.34	0.69	0.69	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	740.83	144.12	83.44	70.80	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	259.99	54.14	36.31	22.72	0.00	0.22	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	188.83	47.00	24.98	16.51	0.85	2.96	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	179.68	45.57	36.55	14.72	0.71	0.47	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	257.98	45.93	19.32	14.59	0.86	0.00	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	198.61	45.14	27.08	27.08	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	263.91	47.65	27.32	21.66	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	519.39	92.43	31.56	25.70	0.00	0.00	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	188.08	65.08	17.46	13.09	0.40	0.40	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	146.73	20.43	19.50	13.93	0.00	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	210.37	32.16	23.46	12.49	0.00	0.76	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	370.53	64.53	30.31	21.83	0.33	0.98	0.65	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	217.89	37.91	21.35	20.92	0.00	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	578.93	109.00	58.80	33.02	0.45	0.00	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	254.87	88.19	20.28	22.05	0.00	2.65	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	144.27	27.26	7.98	13.30	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	240.58	45.64	14.88	14.39	0.50	0.00	1.49	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	382.06	58.96	25.65	19.91	0.00	0.77	0.00	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	166.04	39.62	25.41	12.40	0.00	1.51	0.60	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	455.31	82.66	34.70	25.86	0.00	0.00	0.66	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	224.98	72.51	23.04	14.91	0.00	0.68	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	214.60	45.99	30.66	20.44	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	168.27	28.66	18.29	11.58	0.61	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	403.49	67.35	27.38	14.16	0.00	1.26	0.63	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	219.42	30.57	18.46	15.44	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	370.25	83.07	22.15	20.57	0.00	0.00	3.96	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	426.25	260.74	72.55	26.07	1.13	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	177.03	60.69	5.06	15.17	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	177.03	46.71	27.70	9.69	0.99	0.75	0.25	0.25
Myoblast, donor2	11322-117D8	150.75	38.74	21.29	14.00	0.96	0.00	0.96	1.15
Myoblast, donor3	11398-118D3	212.89	40.02	23.88	15.30	0.34	0.67	0.17	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	13.84	3.69	2.15	7.38	0.31	0.31	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	10.86	0.90	2.11	4.22	0.00	0.30	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	19.51	5.34	3.50	3.68	0.00	0.37	0.00	0.00
Neural stem cells, donor1	11275-116H6	129.93	50.81	18.87	6.90	1.09	2.18	0.00	0.36
Neural stem cells, donor2	11352-117H2	111.69	19.26	7.70	9.63	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	78.51	21.62	5.69	11.38	1.14	0.00	1.14	1.14
Neurons, donor2	11574-120E8	72.87	24.44	6.83	8.37	1.10	0.66	0.00	0.22
Neurons, donor3	11655-122E8	61.66	18.09	6.58	3.29	0.82	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	567.94	161.47	83.52	57.54	1.86	0.00	3.71	5.57
Neutrophils, donor2	11314-117C9	475.42	150.74	104.36	26.09	5.80	2.90	2.90	0.00
Neutrophils, donor3	11390-118C4	941.92	264.49	104.45	76.97	2.44	9.16	0.61	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	37.16	12.94	6.41	8.19	1.19	1.19	0.24	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	66.75	14.33	11.07	8.14	0.33	1.63	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	72.60	13.24	14.24	11.23	0.40	0.20	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	475.31	215.98	53.27	28.22	4.27	0.28	1.93	1.51
Olfactory epithelial cells, donor2	11934-125I8	510.66	128.10	56.45	23.88	6.37	0.14	5.21	4.34
Olfactory epithelial cells, donor3	11935-125I9	457.08	123.27	52.10	21.68	2.38	0.45	1.82	1.25
Olfactory epithelial cells, donor4	11936-126A1	772.46	188.46	61.36	43.24	1.66	0.39	0.88	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	222.07	36.11	13.24	19.86	0.00	1.20	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	194.83	42.33	29.99	14.25	0.64	1.49	0.21	1.06
Osteoblast - differentiated, donor2	11353-117H3	115.45	19.43	26.29	6.86	0.00	1.14	3.43	1.14
Osteoblast - differentiated, donor3	11425-118G3	81.31	18.00	16.76	4.97	1.24	0.62	0.00	0.62
Osteoblast, donor1	11277-116H8	308.40	70.36	29.32	23.45	1.56	0.78	0.00	0.39
Osteoblast, donor2	11354-117H4	383.47	75.15	38.63	28.80	0.70	0.00	0.00	2.11
Osteoblast, donor3	11426-118G4	521.28	110.73	56.34	30.57	1.24	0.53	0.53	0.71
Pancreatic stromal cells, donor1	11249-116E7	172.43	45.99	21.40	16.43	1.68	0.51	0.59	0.42
Pericytes, donor1	11491-119E6	99.69	20.92	12.35	8.46	0.33	1.34	0.22	0.45
Pericytes, donor2	11571-120E5	71.98	13.58	10.64	14.94	0.45	0.91	0.68	0.23
Pericytes, donor3	11652-122E5	424.80	98.06	56.15	24.21	2.24	1.22	1.02	1.22
Perineurial Cells, donor1	11499-119F5	92.79	32.89	12.32	5.88	0.79	0.23	0.00	0.23
Perineurial Cells, donor2	11579-120F4	86.12	16.65	13.99	11.23	0.37	0.64	0.28	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	62.47	15.62	10.84	17.21	0.32	0.64	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	62.19	19.34	17.39	13.96	0.49	0.49	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	50.60	14.24	13.72	13.72	0.00	1.16	0.13	0.26
Placental Epithelial Cells, donor1	11278-116H9	98.30	17.22	4.78	12.44	0.48	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	159.68	23.29	16.63	15.52	3.33	1.11	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	197.70	37.50	17.28	13.35	0.98	0.20	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	143.04	38.29	25.00	11.39	1.90	0.95	0.95	2.53
Preadipocyte - breast, donor1	11467-119B9	148.76	36.20	18.95	9.75	1.13	1.13	0.75	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	594.16	120.87	63.96	37.72	2.87	0.26	1.04	1.04
Preadipocyte - breast, donor2	11328-117E5	237.08	56.96	43.00	16.66	2.48	0.23	1.58	2.03
Preadipocyte - omental, donor1	11468-119C1	157.28	37.93	23.98	11.51	1.28	0.53	0.53	0.75
Preadipocyte - omental, donor2	11329-117E6	305.09	56.74	23.57	13.97	2.62	0.44	1.75	1.31
Preadipocyte - omental, donor3	11403-118D8	408.69	96.12	47.85	21.77	1.43	0.29	1.72	2.15
Preadipocyte - perirenal, donor1	11469-119C2	146.66	26.58	39.37	17.72	0.00	1.97	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	287.77	57.12	33.78	17.20	0.61	1.23	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	286.33	66.94	37.54	24.44	2.48	1.42	2.83	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	183.23	43.59	29.97	11.07	1.36	0.85	0.85	1.02
Preadipocyte - visceral, donor1	11280-116I2	169.43	40.61	25.80	15.00	1.40	2.33	0.47	0.37
Preadipocyte - visceral, donor2	11357-117H7	172.11	40.96	18.87	22.55	1.38	1.38	1.84	0.46
Preadipocyte - visceral, donor3	11429-118G7	128.63	28.00	21.32	11.70	1.15	0.52	1.46	1.36
Prostate Epithelial Cells (polarized), donor1	11253-116F2	47.97	21.72	7.09	7.39	0.75	0.60	0.30	0.45
Prostate Epithelial Cells, donor2	11331-117E8	382.27	77.46	51.46	15.30	3.66	0.54	2.44	1.90
Prostate Epithelial Cells, donor3	11404-118D9	125.66	23.88	8.82	11.02	0.49	0.00	0.61	0.49
Prostate Stromal Cells, donor1	11254-116F3	283.73	75.29	43.05	15.03	1.03	4.10	0.80	0.91
Prostate Stromal Cells, donor2	11332-117E9	322.20	79.79	36.58	23.13	2.87	0.90	2.33	1.97
Prostate Stromal Cells, donor3	11405-118E1	199.79	54.12	37.85	15.12	1.77	1.04	1.77	1.46
Renal Cortical Epithelial Cells, donor1	11516-119H4	424.84	52.19	28.47	47.81	0.73	0.73	0.73	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	304.83	62.80	20.17	20.72	2.01	0.07	0.76	0.69
Renal Epithelial Cells, donor1	11517-119H5	359.63	74.56	22.83	51.74	1.01	1.01	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	369.18	74.69	40.55	51.22	0.71	0.00	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	310.50	56.43	25.41	23.08	2.86	0.42	1.16	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	150.47	18.38	13.62	31.32	0.00	0.00	0.68	3.40
Renal Glomerular Endothelial Cells, donor2	11594-120H1	181.53	17.65	15.23	26.68	0.67	0.27	0.54	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	515.73	71.71	36.19	49.73	0.89	0.00	1.33	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	318.75	46.58	15.97	35.27	1.33	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	351.04	51.06	33.23	39.18	1.98	0.44	0.88	0.22
Renal Mesangial Cells, donor2	11598-120H5	417.57	75.24	46.40	34.48	1.25	0.00	1.25	1.25
Renal Mesangial Cells, donor3	11679-122H5	423.33	71.57	35.79	33.01	1.11	0.00	0.83	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	274.86	44.56	24.43	41.87	0.27	0.00	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	192.71	39.64	19.82	27.83	1.27	0.00	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	538.62	92.18	42.04	43.97	1.74	0.00	0.39	1.54
Retinal Pigment Epithelial Cells, donor0	11215-116A9	87.38	24.11	17.63	11.15	0.00	0.78	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	242.46	54.57	36.95	20.18	0.85	1.14	0.28	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	279.92	59.69	42.19	26.76	1.03	1.03	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	144.52	37.89	22.83	8.28	2.26	1.25	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	76.31	25.12	11.23	10.42	0.27	0.27	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	111.68	35.74	18.76	25.91	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	91.91	19.81	9.36	24.22	1.65	0.55	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	104.41	30.16	16.24	29.58	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	125.21	21.45	10.92	18.20	0.26	0.26	0.26	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	139.13	43.00	13.70	15.19	0.89	0.70	0.50	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	106.63	36.14	7.36	11.71	0.11	0.67	0.22	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	137.19	32.38	12.78	16.25	1.36	0.99	0.62	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	146.38	44.64	15.50	16.20	1.52	0.35	0.82	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	167.80	42.30	12.71	18.95	0.69	0.23	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	177.02	29.71	15.20	24.78	0.14	0.82	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	162.16	46.29	15.43	17.25	0.61	0.91	0.45	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	127.76	38.17	9.14	12.36	0.00	0.54	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	152.35	26.97	15.92	18.22	0.72	0.86	0.57	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	137.58	41.64	12.34	13.41	1.18	0.32	0.97	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	151.13	49.56	12.39	15.49	0.89	0.00	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	198.63	26.00	22.75	31.54	0.19	0.57	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	172.26	49.47	14.07	17.89	0.28	0.28	0.47	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	132.10	47.35	10.15	12.59	0.56	0.94	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	189.11	40.21	18.45	24.42	0.00	0.13	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	161.98	43.22	13.14	16.45	0.78	0.68	0.49	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	153.34	54.61	13.94	13.75	0.38	0.00	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	178.56	32.04	15.16	19.01	0.21	0.32	0.75	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	162.86	54.66	14.02	18.50	0.84	1.12	1.40	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	176.88	47.85	11.62	16.41	0.51	0.34	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	205.12	33.91	19.14	21.33	0.36	0.55	0.18	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	153.17	47.21	12.39	15.21	0.98	0.61	0.86	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	152.59	45.80	12.76	14.78	0.81	0.67	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	172.66	24.53	18.16	23.82	0.71	0.71	0.47	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	165.08	47.02	13.89	13.10	0.40	0.00	1.39	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	171.64	49.81	16.84	19.18	0.70	0.47	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	167.54	24.05	18.45	19.70	0.62	0.62	0.41	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	156.40	49.99	15.26	18.58	0.44	0.44	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	180.48	53.27	19.22	15.25	0.63	0.84	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	182.36	29.61	17.90	22.88	0.40	0.67	0.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	225.13	64.20	20.44	22.82	0.34	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	186.63	50.32	15.42	16.97	0.58	0.77	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	176.75	25.27	19.26	19.94	0.52	1.38	0.86	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	189.29	62.55	21.54	18.52	0.14	0.41	0.55	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	165.81	48.27	17.07	15.76	0.16	0.00	0.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	156.28	26.59	13.80	23.01	0.17	0.68	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	124.73	35.36	11.39	12.13	0.59	0.59	0.44	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	157.80	57.04	19.46	20.26	0.27	0.80	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	90.43	18.80	11.06	17.42	0.28	0.69	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	105.72	36.91	9.52	11.43	0.48	0.00	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	174.94	64.29	15.12	25.60	0.20	0.20	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	92.76	18.46	9.89	14.97	0.94	0.28	0.38	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	98.87	30.05	8.73	10.48	0.35	0.70	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	97.61	35.66	8.16	16.62	0.00	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	111.37	23.62	10.16	20.68	0.24	0.49	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	141.77	47.01	12.81	18.34	0.29	1.89	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	126.55	43.20	15.82	12.78	0.61	0.61	1.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	115.74	19.89	16.28	17.48	1.21	0.90	0.90	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	122.14	35.29	11.76	14.48	1.36	0.68	0.23	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	130.60	44.03	11.38	18.27	1.50	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	79.46	14.41	5.43	14.88	0.35	0.59	0.35	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	89.65	30.95	8.54	14.09	0.00	0.00	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	103.37	29.45	15.02	13.22	0.00	0.60	0.00	1.20
Schwann Cells, donor1	11498-119F4	258.41	46.83	28.96	34.61	1.50	0.56	0.94	0.38
Schwann Cells, donor2	11578-120F3	139.50	30.62	10.21	34.02	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	208.13	43.82	19.94	21.47	2.63	0.22	1.10	1.10
Sebocyte, donor1	11220-116B5	795.91	128.73	63.54	52.59	5.48	0.55	0.55	1.64
Sebocyte, donor2	11301-117B5	613.51	103.40	55.15	41.82	6.43	0.46	1.38	0.92
Sebocyte, donor3	11378-118B1	327.51	60.39	25.56	23.70	1.03	0.41	2.06	0.82
Sertoli Cells, donor1	11255-116F4	359.48	96.08	49.70	13.25	1.66	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	192.06	48.01	36.72	2.82	0.00	2.82	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	92.82	22.26	12.76	9.85	0.79	0.44	0.35	0.09
Skeletal Muscle Cells, donor2	11358-117H8	110.60	17.35	15.90	5.78	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	302.65	34.28	16.72	45.98	1.67	0.00	0.00	1.67
Skeletal Muscle Cells, donor4	11451-119A2	126.30	18.85	11.31	15.87	0.63	0.63	0.00	0.31
Skeletal Muscle Cells, donor5	11455-119A6	116.09	18.28	12.19	15.90	0.59	0.89	0.15	0.00
Skeletal Muscle Cells, donor6	11459-119B1	202.69	32.63	16.93	30.63	0.31	0.46	0.77	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	116.81	26.34	11.34	19.15	0.50	4.28	0.63	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	122.28	28.97	15.27	21.26	1.14	0.43	0.86	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	239.69	44.45	22.72	25.00	0.79	0.79	0.40	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	160.84	34.04	16.60	9.27	1.01	0.84	0.25	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	243.18	46.32	22.44	31.85	0.72	0.72	0.72	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	149.16	28.90	18.44	13.35	0.69	0.55	0.28	0.55
Skin - palm, donor1	10286-104F7	145.05	51.04	40.29	26.86	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	314.55	53.48	26.24	33.73	1.15	0.00	1.01	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	981.47	140.68	98.96	140.68	0.82	0.82	1.64	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	287.83	45.05	18.57	29.99	0.91	0.26	1.30	1.04
Small Airway Epithelial Cells, donor1	11256-116F5	194.19	46.98	27.52	10.15	1.81	0.28	0.56	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	314.09	59.92	38.40	16.03	1.13	0.14	0.84	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	819.56	142.30	41.44	62.17	0.42	0.63	1.27	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	153.35	31.85	15.29	11.24	0.22	0.15	0.37	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	148.12	16.05	31.48	16.05	0.93	0.31	1.54	3.09
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	355.28	46.47	45.36	32.90	1.56	2.45	1.33	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	268.64	39.97	26.45	20.57	1.18	0.59	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	155.36	28.73	13.92	15.03	1.55	0.44	0.22	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	271.31	54.34	40.56	24.02	1.97	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	231.00	49.44	35.54	24.72	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	76.06	18.01	21.02	6.00	1.00	5.00	1.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	355.85	79.05	35.66	19.96	1.86	0.53	0.40	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	137.43	41.23	25.27	12.19	1.55	0.89	0.66	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	310.09	64.91	55.44	17.41	0.51	0.13	0.38	1.15
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	155.31	52.42	19.54	7.81	0.33	1.30	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	355.28	80.62	33.37	15.36	0.59	0.89	0.30	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	396.63	90.40	62.36	19.22	1.28	0.85	1.00	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	365.20	60.35	34.98	37.90	1.30	0.81	0.49	1.14
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	178.70	44.14	28.92	14.61	0.30	0.91	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	87.13	21.72	16.16	16.16	0.51	1.01	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	165.26	6.12	12.24	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	317.10	49.59	46.25	25.27	0.95	1.43	1.91	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	262.50	56.04	24.78	19.76	1.18	0.74	0.29	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	211.79	47.78	32.72	25.40	1.29	2.37	0.65	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	265.02	57.94	27.60	25.08	1.05	2.73	0.10	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	299.30	62.80	36.04	19.64	1.08	0.77	0.15	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	365.40	80.84	59.28	18.32	0.00	0.00	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	262.99	49.91	37.66	22.71	0.60	0.90	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	450.31	68.28	36.87	50.19	0.34	1.02	1.02	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	126.59	42.17	18.69	13.27	1.57	1.81	0.79	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	146.33	40.56	21.44	9.46	1.61	0.81	0.70	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	118.10	27.99	19.57	7.96	0.91	0.23	0.23	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	291.04	53.74	52.53	23.55	1.81	0.00	0.60	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	220.68	32.85	13.25	31.79	1.32	0.79	1.06	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	180.43	29.83	21.70	17.44	2.00	1.20	0.27	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	179.19	48.46	42.20	15.90	2.13	3.26	1.00	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	70.01	19.79	16.23	7.61	0.25	0.76	0.00	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	166.15	33.47	23.82	15.08	0.15	0.30	0.45	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	75.02	17.25	18.75	11.25	0.75	0.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	211.92	78.83	23.26	93.04	7.75	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	184.63	46.04	26.97	22.32	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	222.15	44.93	35.85	13.63	1.51	1.01	1.51	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	258.24	47.32	38.86	12.85	1.25	0.00	1.25	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	153.69	28.91	19.76	15.93	0.59	0.59	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	158.87	28.41	9.50	23.41	0.25	0.58	0.00	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	123.80	28.96	13.08	24.76	0.00	2.34	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	631.95	136.29	67.93	21.01	2.30	2.88	0.58	0.86
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	617.25	139.46	76.49	26.77	3.82	1.53	1.53	2.80
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	334.70	60.17	45.13	26.32	1.50	1.13	0.38	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	260.76	41.78	31.44	23.90	0.84	0.28	0.42	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	427.82	87.56	68.87	17.93	1.68	0.75	0.84	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	202.38	34.76	18.57	33.81	0.48	0.48	1.43	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	676.49	155.85	69.73	27.16	4.16	2.45	0.73	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	336.06	46.84	37.34	13.48	0.88	2.21	0.66	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	163.55	23.99	13.17	20.19	0.29	1.17	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	149.27	31.49	21.57	19.24	0.19	2.14	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	321.05	66.91	42.31	30.15	1.32	0.53	2.12	2.38
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	136.88	18.97	21.20	13.02	1.49	0.37	1.86	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	244.35	57.49	47.43	20.48	1.08	0.00	0.72	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	256.65	47.98	32.08	23.85	0.85	0.57	0.28	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	344.64	60.26	42.14	29.93	1.18	0.00	1.58	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	117.83	22.09	21.08	11.17	0.51	1.27	0.76	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	164.92	38.73	27.95	23.96	0.40	0.80	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	132.93	32.60	24.66	10.45	1.67	1.25	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	77.46	22.00	18.33	12.38	0.00	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	566.74	138.36	53.19	24.24	3.03	0.50	2.69	1.68
Synoviocyte, donor2	11368-117I9	39.73	12.74	10.39	5.03	0.50	0.67	0.50	0.00
Synoviocyte, donor3	11440-118H9	23.01	8.71	6.26	4.24	0.22	0.67	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	291.22	60.39	28.23	50.74	1.43	1.07	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	150.64	25.77	23.78	13.87	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	234.79	47.93	25.01	26.63	0.93	1.16	0.69	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	288.17	52.62	24.52	24.66	1.00	0.29	0.43	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	277.55	49.48	23.58	22.81	0.39	0.77	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	262.85	41.80	37.80	17.75	0.57	0.00	2.86	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	70.12	27.43	10.58	8.24	0.49	0.62	0.00	0.12
Urethra, donor2	10319-105A4	446.01	174.45	88.12	25.18	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	577.81	79.96	45.69	43.30	2.39	0.53	0.53	1.33
Urothelial Cells, donor2	11600-120H7	493.90	75.31	41.66	34.85	4.01	0.80	0.80	0.00
Urothelial Cells, donor3	11681-122H7	516.17	85.04	34.61	35.30	1.60	0.46	0.69	0.23
Urothelial cells, donor0	11216-116B1	626.11	108.10	42.35	29.42	2.67	0.67	0.22	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	215.33	42.71	47.16	31.14	1.78	0.89	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	211.58	45.75	57.18	22.87	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	206.04	67.08	45.18	24.64	1.37	0.00	2.74	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	146.69	46.83	27.89	24.79	1.38	1.72	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	151.65	55.78	24.98	18.59	2.32	1.74	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	200.96	43.73	48.94	45.81	1.04	2.08	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	144.09	32.12	43.14	34.88	1.84	2.75	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	178.93	41.99	57.51	15.52	0.91	3.65	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	94.49	37.63	19.61	11.72	0.49	0.62	0.37	0.25
Wilms' tumor cell line:HFWT	10597-108E3	109.12	40.48	16.72	25.52	0.00	0.88	2.64	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	89.66	22.07	10.06	21.51	0.28	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	181.85	33.06	37.20	10.33	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.25	0.25	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	20.90	9.98	4.41	9.52	0.23	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	13.77	2.61	1.19	11.16	0.12	0.24	0.12	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	72.38	10.34	1.09	26.67	1.09	0.27	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	34.57	6.46	3.65	14.62	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	40.82	6.77	1.90	13.53	0.00	0.63	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	8.44	4.36	1.09	5.44	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	76.67	9.69	4.41	26.88	0.44	2.20	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	55.95	8.17	2.86	36.75	0.00	0.00	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	43.88	6.99	3.88	13.98	0.00	0.39	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	43.42	10.30	6.99	13.06	0.37	0.55	0.37	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	237.93	39.01	23.40	46.81	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	41.13	8.13	1.86	16.03	0.23	0.46	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	68.61	16.05	6.73	28.22	1.04	1.04	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	56.11	12.27	5.26	28.64	0.29	2.34	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	72.04	23.24	10.22	27.89	0.00	1.39	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	241.41	43.18	8.64	48.53	1.23	0.82	0.82	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	201.36	53.72	28.85	32.23	0.31	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	210.79	72.54	20.91	21.76	0.43	1.28	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	183.49	60.96	18.80	21.53	0.91	2.43	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	182.45	61.14	14.92	16.85	0.96	3.85	0.48	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	87.76	19.38	8.46	24.72	0.67	0.22	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	115.21	52.03	27.87	50.17	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	132.58	35.03	21.47	15.82	0.75	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	166.17	31.40	9.16	64.11	0.00	0.44	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	183.70	33.74	16.87	24.37	0.00	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	50.87	28.73	10.60	13.19	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	106.72	29.16	13.03	11.63	0.16	0.93	0.00	0.16
adipose, donor1	10184-103D4	57.47	28.15	12.90	6.45	0.59	1.17	0.00	0.00
adipose, donor2	10185-103D5	32.04	17.44	6.08	6.08	0.00	0.81	0.41	0.00
adipose, donor3	10186-103D6	80.05	34.31	11.71	5.99	0.82	0.54	0.54	0.54
adipose, donor4	10187-103D7	178.55	39.87	15.60	8.67	0.87	0.87	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	112.53	18.78	6.79	80.80	0.16	0.00	0.32	0.00
adrenal gland, adult, pool1	10081-102A9	54.57	7.28	10.91	7.28	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	84.32	40.02	15.01	8.58	0.71	0.00	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	32.69	11.13	2.78	3.25	0.00	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	115.29	25.70	7.44	9.13	1.01	1.01	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	34.17	12.37	4.42	7.95	0.00	0.29	0.00	0.00
amygdala - adult, donor10196	10167-103B5	132.81	11.86	7.11	30.83	0.00	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	160.19	25.55	14.19	15.41	0.20	0.20	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	88.44	26.79	9.68	13.88	0.00	1.94	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	199.78	72.71	19.35	36.54	0.89	0.64	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	40.82	16.77	5.96	7.06	0.22	0.00	0.00	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	101.21	35.41	15.03	21.38	0.67	1.00	0.00	0.00
aorta, adult, pool1	10052-101G7	816.11	223.00	112.97	45.11	2.75	1.18	2.55	0.98
appendix, adult	10189-103D9	181.25	71.03	43.08	19.79	0.00	0.00	0.00	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	41.62	10.32	7.91	9.63	0.34	1.03	0.34	0.00
artery, adult	10190-103E1	118.21	32.61	13.59	10.87	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	304.80	68.96	21.44	37.67	1.74	0.29	0.29	0.29
b cell line:RPMI1788	10427-106D4	22.16	5.65	1.34	13.53	0.15	0.30	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	610.94	135.95	56.04	14.98	4.99	0.83	2.50	2.77
bile duct carcinoma cell line:HuCCT1	10432-106D9	189.23	59.44	18.16	27.59	0.69	0.60	0.40	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	37.49	16.57	2.68	5.69	0.17	0.17	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	76.06	25.72	13.98	12.86	0.00	1.12	0.00	0.56
bladder, adult, pool1	10011-101C2	417.83	144.17	57.04	20.42	1.30	0.43	0.87	0.65
blood, adult, pool1	10053-101G8	115.16	48.72	46.51	11.07	4.43	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	301.43	36.82	23.12	20.55	0.00	0.00	0.86	0.00
bone marrow, adult	10192-103E3	220.67	62.08	23.62	24.29	1.35	0.67	2.02	0.67
brain, adult, donor1	10084-102B3	58.43	11.28	5.13	18.45	0.00	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	72.16	13.92	6.35	9.24	0.45	0.33	0.33	0.00
brain, fetal, pool1	10085-102B4	32.06	10.69	2.67	8.01	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	133.80	53.52	32.05	27.75	0.33	0.33	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	59.54	25.96	7.11	29.96	0.00	0.12	0.25	0.12
breast, adult, donor1	10080-102A8	172.36	43.56	22.10	15.78	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	97.95	33.54	20.96	23.12	1.40	0.25	0.25	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	64.32	29.07	18.86	11.75	0.31	0.31	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	41.67	23.71	9.44	24.40	1.38	0.23	0.23	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	37.52	22.51	8.23	8.47	0.00	0.00	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	20.69	8.93	4.70	15.52	0.00	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	68.25	20.45	8.75	13.13	0.22	1.09	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	19.33	7.29	1.27	15.53	0.00	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	51.11	18.10	5.59	17.30	0.00	0.00	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	196.88	16.12	4.61	69.08	0.00	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	227.23	20.25	11.38	38.15	0.17	0.17	0.00	0.33
caudate nucleus, adult, donor10258	10379-105H1	191.80	13.75	5.35	43.56	2.29	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	136.97	44.68	10.62	45.41	0.00	2.93	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	26.22	8.74	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	33.52	15.37	8.97	4.91	0.00	0.00	0.43	0.21
cerebellum, adult, pool1	10083-102B2	8.28	5.17	2.07	2.41	0.00	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	41.51	24.08	12.45	9.96	0.00	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	121.28	33.28	10.09	13.87	0.00	0.50	0.50	0.00
cerebrospinal fluid, donor2	10294-104G6	71.63	15.35	2.92	7.31	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	41.12	13.80	7.48	9.49	0.14	0.58	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	85.34	22.87	10.44	8.95	0.17	0.33	0.50	0.17
cervix, adult, pool1	10013-101C4	209.25	68.45	18.27	25.30	0.63	1.78	0.52	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	226.29	61.87	21.74	13.24	1.67	0.14	0.00	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	377.51	78.38	36.58	45.72	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	328.71	65.99	24.98	25.85	1.62	0.25	1.12	0.62
choriocarcinoma cell line:SCH	10785-110H2	106.83	21.07	8.87	21.56	0.37	0.37	0.37	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	92.97	21.82	9.25	26.33	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	85.48	30.49	7.98	9.97	0.28	0.00	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	387.58	80.74	28.93	18.10	1.49	0.10	1.99	1.39
chorionic membrane cells, donor3	12240-129G8	158.80	41.76	17.58	12.09	1.10	0.00	1.10	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	5.05	0.00	1.01	8.08	0.00	3.03	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	109.11	19.79	8.84	21.71	0.38	0.00	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	50.68	21.33	12.88	11.62	0.21	0.21	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	4.37	19.52	17.46	1.80	0.26	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	9.19	21.04	18.62	2.18	0.00	0.24	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	9.37	14.86	16.90	2.24	0.00	0.20	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	4.42	17.96	13.54	0.29	0.29	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	148.30	22.94	22.15	25.28	0.26	0.52	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	141.03	29.49	11.43	56.92	2.29	0.00	1.37	0.91
clear cell carcinoma cell line:TEN	10636-108I6	99.59	34.35	9.72	15.79	0.87	0.87	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	69.74	24.89	8.60	15.38	0.18	0.18	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	20.90	13.30	7.98	15.20	0.00	0.76	0.00	0.00
colon, adult, donor1	10082-102B1	301.08	86.87	39.27	15.47	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	158.28	47.35	21.74	10.46	0.24	0.47	0.24	0.24
colon, fetal, donor1	10070-101I7	394.28	50.06	25.34	22.87	0.00	1.24	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	201.67	18.33	13.75	64.17	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	33.14	7.22	2.12	5.95	0.85	0.42	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	62.49	13.28	3.47	7.85	0.45	0.00	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	70.08	17.63	4.94	11.14	0.42	0.14	0.28	0.14
corpus callosum, adult, pool1	10042-101F6	24.21	11.94	4.31	2.87	0.44	0.22	0.00	0.11
cruciate ligament, donor2	10295-104G7	202.62	58.35	47.01	21.07	0.81	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	65.01	14.45	8.03	16.05	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	57.12	6.48	3.12	16.08	0.24	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.23	0.23	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	55.65	23.08	7.95	12.82	0.00	1.03	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	63.07	11.31	6.02	6.02	0.24	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	255.15	88.21	47.34	13.46	0.00	0.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	164.19	47.53	15.84	28.80	0.00	1.44	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	192.00	58.12	18.39	17.66	0.74	0.00	0.74	0.74
dura mater, adult, donor1	10041-101F5	164.02	80.19	21.06	10.08	0.99	0.74	0.41	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	31.31	6.66	1.78	3.55	0.44	0.22	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	38.69	12.61	4.44	4.87	0.43	0.00	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	212.73	59.81	28.36	30.83	0.00	1.23	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	229.15	64.17	27.55	29.67	0.91	0.91	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	232.49	77.19	28.40	28.40	0.00	0.93	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	313.92	85.38	34.15	34.15	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	119.33	53.97	11.73	9.72	0.00	0.00	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	117.44	33.71	10.33	20.66	0.72	0.54	0.36	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	50.17	27.66	6.27	6.91	0.48	0.00	0.16	0.80
epidermoid carcinoma cell line:A431	10426-106D3	400.62	75.37	25.90	40.13	0.44	0.11	0.33	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	574.56	122.63	37.18	53.12	2.86	0.55	0.33	0.11
epididymis, adult	10197-103E8	140.87	48.35	20.72	14.86	0.63	1.67	0.63	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	69.54	19.16	6.39	17.39	0.53	0.00	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	97.92	32.64	14.94	9.04	0.00	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	57.14	17.82	8.13	12.58	0.79	0.13	0.79	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	39.76	13.48	6.59	9.74	0.39	0.00	0.20	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	68.90	21.29	7.95	12.21	0.56	0.56	0.22	0.11
esophagus, adult, pool1	10015-101C6	254.51	79.85	30.90	12.85	0.96	0.21	0.74	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	87.29	52.47	10.39	7.39	0.13	0.13	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	108.66	21.73	4.83	14.49	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	50.50	14.73	14.73	4.21	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	25.30	5.95	7.44	11.91	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	75.67	8.03	10.32	12.61	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	134.08	20.40	26.23	7.29	2.91	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	55.17	23.64	13.47	6.36	0.76	0.76	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	246.83	52.44	27.44	39.11	0.77	0.26	0.64	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	203.23	59.83	25.64	32.53	0.71	0.00	0.47	0.95
frontal lobe, adult, pool1	10040-101F4	80.97	15.48	4.60	14.64	0.28	0.19	0.00	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	70.86	14.71	5.70	16.81	0.30	0.30	0.30	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	196.22	58.15	22.86	16.18	0.91	0.18	0.27	0.09
gall bladder, adult	10198-103E9	290.93	96.81	49.74	18.59	0.72	0.72	0.72	0.48
gamma delta positive T cells, donor1	11937-126A2	11.81	3.22	2.68	4.29	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	23.53	3.36	11.95	5.23	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	44.57	14.36	5.07	6.13	0.42	0.21	0.42	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	69.82	32.11	13.93	17.21	0.00	0.19	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	55.42	10.33	6.89	13.12	0.33	0.16	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	55.83	8.24	7.32	31.12	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	74.25	28.33	9.82	10.28	0.69	0.69	0.46	0.23
giant cell carcinoma cell line:LU65	10487-107B1	23.06	5.28	1.49	5.28	0.00	0.11	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	208.40	57.10	22.53	40.17	0.84	0.14	0.70	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	68.34	23.45	9.23	6.98	0.25	0.00	0.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	82.75	33.78	10.45	4.75	0.00	0.95	0.32	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	78.65	30.76	12.08	5.34	0.28	0.70	0.42	0.28
glioblastoma cell line:T98G	10485-107A8	92.27	37.64	17.44	9.05	0.44	0.11	0.55	0.66
glioma cell line:GI-1	10413-106B8	105.73	33.97	12.01	4.98	0.88	0.00	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	98.40	18.22	4.37	26.24	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	79.33	20.99	10.74	8.30	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	49.29	12.32	4.11	19.17	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	54.89	12.26	4.26	11.19	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	227.58	58.73	9.79	63.63	0.00	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	5.23	0.00	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	355.83	86.40	42.56	22.40	1.28	0.32	0.64	0.64
hIPS +CCl2, biol_rep1	14383-156B9	168.04	23.87	10.56	33.52	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	130.78	16.00	10.97	21.95	0.00	0.46	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	157.80	27.70	17.39	38.00	0.64	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	217.03	8.62	14.37	56.05	0.00	0.00	2.87	1.44
hIPS, biol_rep2	14381-156B7	193.41	13.03	8.92	32.92	0.69	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	69.52	5.52	5.52	14.35	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	2.87	0.29	0.00	1.15	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	214.06	64.88	40.36	13.75	0.60	1.79	0.90	0.60
heart - pulmonic valve, adult	10206-103F8	315.86	115.57	60.92	17.00	0.52	0.52	0.26	0.78
heart - tricuspid valve, adult	10207-103F9	252.29	76.60	40.80	17.49	0.83	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	72.24	19.79	14.69	11.63	0.61	0.20	0.61	0.00
heart, adult, diseased, donor1	10051-101G6	75.37	25.98	15.33	17.46	0.43	0.00	0.85	0.00
heart, adult, pool1	10016-101C7	98.20	34.50	15.41	10.35	0.00	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	120.34	35.01	15.61	17.56	0.62	1.64	0.21	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	949.33	215.35	102.43	40.73	0.93	0.00	0.31	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	76.11	41.62	15.46	19.03	1.19	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	183.31	36.13	16.24	18.78	0.99	2.10	0.88	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	163.85	36.90	18.81	21.48	1.09	2.31	0.36	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	181.79	37.79	15.76	16.57	0.81	2.93	0.20	0.30
hepatoma cell line:Li-7	10484-107A7	129.01	58.17	16.02	5.23	0.67	0.00	0.22	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	26.33	6.13	2.31	10.35	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	94.63	14.19	5.68	19.87	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	87.97	20.00	10.20	12.45	0.61	0.20	0.20	0.20
hippocampus, adult, donor10258	10374-105G5	77.18	7.47	10.46	18.92	1.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	65.91	21.15	8.11	32.43	0.00	1.41	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	129.39	40.89	11.60	20.14	0.61	1.22	1.22	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	120.76	40.45	11.19	16.89	0.39	0.39	0.79	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	143.70	49.00	10.16	16.50	0.76	1.02	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	61.46	30.45	13.53	9.02	0.00	1.13	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	59.39	29.69	14.46	7.75	1.29	0.26	1.81	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	56.56	33.03	21.64	11.01	0.00	0.38	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	50.80	27.44	10.51	8.47	0.29	0.58	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	38.78	20.03	10.77	6.89	0.22	0.43	0.22	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	55.47	32.95	6.67	7.51	0.00	0.00	1.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	76.72	26.28	9.47	8.76	0.47	0.24	0.47	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	93.22	34.88	10.77	8.04	0.80	0.48	0.96	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	76.76	24.91	12.12	8.75	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	88.88	29.26	7.82	10.64	0.31	0.78	0.63	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	92.36	23.09	6.88	17.69	1.97	0.00	0.49	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	77.68	28.80	5.24	13.09	0.00	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	67.58	38.18	12.98	5.73	0.57	0.19	0.76	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	71.95	29.22	21.80	5.23	0.44	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	58.47	31.98	19.49	7.00	0.00	0.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	25.06	12.43	4.33	6.03	0.75	0.38	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	25.01	6.82	4.09	3.64	0.00	0.45	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	31.95	14.41	7.52	5.95	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	76.92	37.23	14.53	5.06	0.49	0.16	0.65	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	79.54	29.90	11.03	5.52	1.45	0.87	0.87	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	98.64	34.68	14.95	4.48	0.60	1.20	0.00	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	109.92	43.60	8.13	17.74	0.55	0.74	1.11	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	109.26	33.95	11.70	17.97	0.29	0.00	1.14	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	128.21	49.00	12.25	15.52	0.00	0.00	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	85.20	26.41	18.31	10.21	0.70	0.70	0.70	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	68.10	26.29	12.35	6.02	0.00	0.32	0.63	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	85.94	36.62	19.67	9.08	0.00	0.00	0.61	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	37.75	13.96	10.34	5.69	0.00	0.52	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	38.52	11.29	12.62	5.31	1.33	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	36.94	16.93	10.00	4.62	0.00	0.77	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	115.04	36.81	17.13	9.97	0.77	0.26	1.02	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	68.15	33.32	11.36	11.36	0.00	0.00	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	185.50	78.30	22.52	13.44	1.01	1.34	1.68	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	101.67	32.36	9.66	15.21	0.48	1.69	0.24	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	116.76	28.97	8.91	19.16	0.45	0.00	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	120.00	41.46	10.73	18.54	0.98	1.46	0.98	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	80.99	32.70	21.70	13.45	0.61	0.31	0.92	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	117.12	42.29	19.52	32.53	0.00	6.51	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	77.11	38.06	22.50	7.28	0.33	0.00	0.99	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	36.67	13.68	7.66	7.66	0.55	0.55	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	40.89	16.65	7.60	8.32	0.36	0.00	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	38.43	12.81	7.12	5.69	0.71	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	72.80	31.03	16.71	10.74	1.19	1.19	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	127.71	47.40	14.49	9.89	1.35	0.27	0.68	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	144.40	56.57	21.82	10.78	0.54	0.27	0.54	0.27
immature langerhans cells, donor1	11904-125F5	4.84	1.45	0.00	1.21	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	6.34	0.79	0.00	0.79	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	132.96	20.63	7.00	19.97	0.38	0.09	0.19	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	33.82	7.48	3.58	8.78	0.00	0.00	0.33	0.00
kidney, adult, pool1	10017-101C8	67.79	20.63	5.11	8.61	0.90	0.00	0.00	0.00
kidney, fetal, pool1	10045-101F9	50.08	14.29	5.02	9.90	0.21	1.27	0.14	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	137.05	30.11	12.36	23.58	0.57	0.71	0.57	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	30.00	11.47	5.67	7.19	0.28	0.14	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	301.49	82.57	15.96	26.79	0.00	0.00	0.00	0.55
left atrium, adult, donor1	10079-102A7	144.93	37.59	22.34	15.26	0.00	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	82.42	26.80	12.64	9.61	0.51	1.01	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	171.83	42.41	19.15	16.14	0.27	0.82	0.55	0.55
leiomyoma cell line:10964C	10569-108B2	94.48	26.23	17.60	10.06	1.44	0.00	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	155.44	39.67	28.26	2.17	0.54	1.09	0.00	0.54
leiomyoma cell line:15425	10571-108B4	147.63	40.06	25.74	11.66	2.19	0.73	2.19	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	146.04	31.75	6.35	12.70	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	661.83	161.02	83.64	40.78	0.00	0.00	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	125.38	30.22	21.13	21.84	0.47	0.12	0.00	0.12
liposarcoma cell line:KMLS-1	10782-110G8	178.86	60.45	35.62	9.06	0.62	0.16	0.16	1.09
liposarcoma cell line:SW 872	10726-110A6	236.25	64.09	27.05	24.73	0.24	0.37	0.24	0.37
liver, adult, pool1	10018-101C9	91.89	26.25	13.45	5.51	0.49	0.16	0.32	0.00
liver, fetal, pool1	10086-102B5	104.42	28.22	19.75	7.53	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	65.62	22.02	8.17	6.71	0.15	0.15	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	53.89	17.90	6.09	4.06	0.55	0.18	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	13.26	3.39	3.67	4.23	0.00	0.00	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	53.84	19.77	8.41	10.09	0.42	0.42	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	54.67	39.58	7.75	9.00	0.42	0.83	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	57.91	19.99	5.52	25.51	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	61.03	22.80	8.83	11.34	0.40	0.00	0.26	0.00
lung, adult, pool1	10019-101D1	104.19	29.65	9.45	16.89	0.12	0.35	0.00	0.24
lung, fetal, donor1	10068-101I5	86.48	17.12	8.85	25.97	0.00	3.14	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	65.52	17.41	11.00	16.04	0.46	0.00	0.00	0.46
lymph node, adult, donor1	10077-102A5	102.25	29.35	9.94	15.15	0.00	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	1.97	0.44	0.66	3.29	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	128.27	37.38	10.19	12.74	0.00	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	197.58	59.49	27.53	10.66	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	156.06	48.15	25.11	7.47	0.00	0.83	0.21	0.00
mature adipocyte, donor3	12233-129G1	143.42	37.22	24.42	7.59	0.47	0.47	0.00	0.00
mature adipocyte, donor4	12234-129G2	80.81	26.32	15.00	4.21	0.00	0.26	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	13.82	4.53	3.57	4.77	0.00	0.00	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	127.47	19.18	5.64	22.56	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	163.86	34.21	17.29	15.45	0.18	0.00	0.37	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	96.26	12.39	8.58	17.79	0.00	0.00	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	79.75	18.77	7.25	11.94	0.00	0.85	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	135.00	24.47	6.08	27.84	1.01	0.00	0.34	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	189.30	32.26	18.89	19.74	0.64	0.42	0.21	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	69.35	0.00	19.26	73.20	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	14.35	0.00	71.77	0.00	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	92.60	29.07	7.90	21.54	0.00	1.79	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	62.30	29.85	13.63	7.14	0.65	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	49.38	20.90	8.51	2.32	0.31	0.00	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	37.39	15.84	4.49	4.98	0.00	0.24	0.00	0.00
medulla oblongata, newborn, donor10223	10361-105F1	37.84	23.96	7.99	4.86	0.35	0.69	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	21.48	17.49	9.08	6.20	0.00	0.00	0.44	0.00
medulloblastoma cell line:ONS-76	10759-110E3	245.89	50.38	18.34	27.14	0.24	0.12	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	118.59	15.24	7.33	14.66	0.43	0.14	0.14	0.14
melanoma cell line:G-361	10465-106H6	63.79	9.23	7.06	11.67	0.54	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	107.28	41.25	19.18	9.59	0.54	0.18	1.81	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	29.96	7.05	2.64	22.03	0.00	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	52.88	10.89	4.15	13.22	0.26	0.00	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	128.42	25.16	20.10	9.67	0.77	0.92	0.61	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	225.95	38.36	23.27	9.09	2.36	0.55	0.55	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	84.48	12.84	16.56	6.63	1.24	0.83	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	125.73	22.76	20.51	8.99	0.70	0.28	0.42	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	183.90	33.12	15.60	9.63	0.77	0.39	0.77	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	43.73	10.41	4.16	6.94	0.00	0.00	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	89.76	17.85	20.60	4.63	0.17	0.69	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	107.65	19.55	14.15	7.02	1.04	0.92	0.12	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	108.10	20.03	16.45	9.02	1.46	0.66	0.40	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	173.39	29.44	22.42	13.37	0.54	0.14	0.54	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	268.45	45.52	27.60	12.09	1.42	0.00	0.57	1.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	167.97	41.50	28.65	11.86	0.99	0.00	0.66	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	273.70	49.40	32.93	18.54	0.83	3.04	0.69	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	160.93	39.45	24.44	14.66	0.70	1.05	0.35	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	222.54	40.22	26.75	10.62	1.43	0.20	0.82	1.84
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	351.55	71.53	37.38	22.65	2.52	0.36	1.44	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	214.76	43.35	31.03	13.24	1.14	1.66	0.83	0.83
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	251.70	59.28	42.86	10.03	1.60	0.46	0.91	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	234.95	39.44	26.43	16.78	0.42	1.26	1.26	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	253.89	49.17	27.50	14.79	0.60	0.30	1.20	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	167.45	29.50	25.82	8.05	1.14	1.49	0.53	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	322.51	72.16	48.23	20.62	2.21	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	474.45	105.31	50.36	22.03	3.43	0.57	2.00	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	266.50	72.41	37.47	26.52	1.26	0.00	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	182.21	28.31	38.82	19.18	0.91	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	162.93	29.42	26.86	13.56	0.77	1.53	0.51	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	173.02	36.91	37.17	14.40	0.79	0.52	1.05	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	184.54	48.68	36.97	15.40	0.62	0.31	0.00	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	138.62	29.89	27.07	12.94	1.18	0.00	0.94	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	177.35	32.83	32.49	17.26	1.35	1.02	0.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	174.48	41.26	26.33	18.86	0.00	1.18	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	140.41	30.58	31.05	13.90	0.93	1.39	1.39	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	96.61	0.00	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	202.76	44.70	29.42	16.15	0.58	0.29	0.87	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	166.66	35.03	27.22	15.39	0.45	0.67	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	173.77	35.81	32.69	16.82	1.92	1.20	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	258.86	56.47	46.20	19.07	0.00	2.20	0.73	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	174.54	34.24	22.82	14.43	0.67	0.00	1.01	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	185.45	29.88	29.07	17.19	0.41	2.05	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	169.68	27.06	27.92	17.61	0.86	0.86	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	177.74	27.34	21.88	21.88	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	154.95	25.82	30.99	10.33	0.00	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	187.08	43.85	36.38	16.56	0.32	1.30	0.97	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	162.96	32.01	20.37	11.64	0.00	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	152.46	43.71	36.78	8.00	1.60	2.13	0.00	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	160.28	37.62	22.90	16.36	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	180.75	32.26	31.10	13.61	0.39	1.17	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	155.31	39.88	18.89	14.69	0.00	4.20	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	144.05	28.81	27.82	13.91	0.99	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	157.32	38.14	23.84	23.84	4.77	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	147.65	35.58	36.17	15.42	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	186.42	34.12	36.55	10.97	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	54.10	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	145.68	38.64	32.94	9.50	2.53	1.27	1.27	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	42.42	11.04	20.35	5.52	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	40.83	4.30	8.60	10.75	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	47.90	27.94	15.97	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	6.89	3.44	10.33	0.00	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	25.26	5.70	6.52	6.11	0.41	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	26.22	8.74	7.15	0.79	0.00	0.00	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	23.58	5.31	5.90	3.54	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	27.12	8.42	4.99	5.92	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	29.41	8.02	4.01	4.01	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	117.08	17.74	13.01	8.28	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	71.90	12.84	12.84	15.41	2.57	2.57	0.00	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	107.39	14.46	23.41	8.26	1.38	0.00	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	206.83	31.17	27.71	9.40	0.99	0.99	1.48	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	199.63	26.92	24.67	4.49	2.24	2.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	201.63	28.62	21.63	13.36	1.27	1.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	330.04	51.98	29.82	16.93	0.81	2.01	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	344.53	63.24	23.99	15.26	2.18	0.00	4.36	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	369.98	63.35	27.88	17.74	1.27	3.80	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	200.27	31.56	24.88	7.89	0.00	0.61	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	230.47	40.67	31.63	22.59	4.52	0.00	0.00	13.56
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	223.22	28.01	20.59	5.77	0.00	0.00	0.00	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	115.88	25.40	12.70	5.95	0.20	0.60	0.40	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	129.80	22.07	15.58	8.11	1.62	0.97	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	148.72	26.48	20.37	13.24	3.06	1.02	1.02	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	652.24	157.06	26.31	37.91	0.00	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	125.21	19.84	9.69	28.35	0.24	0.00	0.71	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	271.06	76.92	34.98	12.97	1.16	0.93	0.70	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	277.78	55.56	21.37	4.27	8.55	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	296.64	69.87	12.74	12.84	0.31	0.00	0.72	0.41
mesothelioma cell line:Mero-25	10850-111F4	319.32	80.34	26.55	20.43	1.36	0.00	1.13	1.82
mesothelioma cell line:Mero-41	10851-111F5	220.27	71.39	37.65	16.14	2.93	0.00	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	135.52	31.89	19.26	12.18	0.44	0.66	0.89	0.22
mesothelioma cell line:Mero-82	10853-111F7	223.91	58.87	31.27	14.19	1.58	0.79	1.58	0.00
mesothelioma cell line:Mero-83	10854-111F8	321.38	88.86	28.94	17.36	3.06	0.34	1.53	0.51
mesothelioma cell line:Mero-84	10855-111F9	195.39	46.26	20.73	26.04	1.52	0.51	1.26	1.01
mesothelioma cell line:Mero-95	10856-111G1	108.28	32.51	15.53	15.32	0.21	0.21	0.41	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	207.39	52.18	27.00	15.24	1.49	0.17	0.66	0.99
mesothelioma cell line:NCI-H226	10846-111E9	241.08	65.70	39.82	11.40	1.27	0.00	1.63	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	60.98	16.06	10.42	8.54	0.34	0.17	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	47.33	17.30	6.62	5.85	0.51	0.00	0.25	0.00
mesothelioma cell line:No36	10857-111G2	122.00	33.93	11.09	7.50	0.33	0.00	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	130.60	41.18	26.28	8.40	0.81	0.00	0.27	0.54
migratory langerhans cells, donor1	11901-125F2	10.56	2.88	0.38	4.61	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	4.64	1.34	0.49	3.42	0.00	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	6.64	2.15	0.72	5.92	0.00	0.00	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	350.64	117.86	38.20	16.65	2.94	0.33	3.26	4.24
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	324.90	61.04	23.52	34.97	1.48	0.21	1.48	1.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	338.16	83.62	31.79	33.17	0.00	0.23	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	46.62	8.56	3.04	16.37	0.00	0.00	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	120.30	26.61	6.65	34.37	1.29	2.96	0.18	0.18
myeloma cell line:PCM6	10474-106I6	18.38	5.34	0.79	3.76	0.20	0.20	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	572.73	151.68	61.38	57.83	0.00	0.00	2.03	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	63.75	18.63	10.20	12.16	0.59	0.00	0.20	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	105.63	16.38	9.58	10.70	0.33	0.00	0.22	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	115.97	18.83	7.35	12.28	0.15	0.15	0.22	0.07
nasal epithelial cells, donor2	12227-129F4	173.32	28.15	13.80	12.14	0.00	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	30.60	14.49	4.83	9.43	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	81.20	16.84	7.30	17.77	0.00	0.94	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	21.51	11.60	6.33	1.90	0.42	0.42	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	97.83	35.59	20.31	13.42	0.00	0.56	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	40.09	8.54	3.56	8.30	0.24	0.24	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	21.06	7.76	3.48	5.70	0.16	0.00	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	64.00	26.77	13.08	15.30	0.20	0.40	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	19.71	7.63	2.54	25.43	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	526.48	123.50	78.52	23.95	0.27	0.80	0.27	0.27
neutrophil PMN, donor1	12133-128D9	327.25	163.62	0.00	44.62	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	398.42	13.28	13.28	39.84	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	369.35	66.29	37.88	37.88	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	16.57	5.24	1.52	11.67	0.00	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	4.80	2.40	0.80	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	182.42	54.18	22.12	16.03	1.60	1.92	1.28	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	387.58	116.93	52.03	15.77	3.68	1.05	2.89	2.10
nucleus accumbens, adult, pool1	10037-101F1	121.30	15.65	6.47	25.12	0.09	0.28	0.19	0.19
occipital cortex - adult, donor10196	10172-103C1	168.95	16.48	10.30	35.03	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	170.41	49.92	33.81	17.98	0.27	0.00	0.54	0.54
occipital cortex, newborn, donor10223	10355-105E4	93.90	20.74	6.55	24.02	0.00	1.09	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	62.19	8.40	4.99	12.86	0.00	0.00	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	32.18	14.59	7.72	16.31	0.00	0.43	0.00	0.00
occipital pole, adult, pool1	10036-101E9	72.85	14.35	4.10	13.88	0.16	0.08	0.00	0.00
olfactory region, adult	10195-103E6	94.95	13.95	9.93	17.58	0.38	0.19	0.00	0.19
optic nerve, donor1	10277-104E7	62.03	22.01	10.01	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	83.61	25.52	9.45	4.44	0.34	0.34	0.00	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	71.30	19.37	4.12	25.97	0.00	0.96	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	237.56	58.59	23.37	22.69	1.52	0.51	1.35	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	118.74	27.72	15.48	16.06	1.27	0.46	0.58	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	489.45	146.40	39.98	26.16	1.76	0.00	0.88	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	378.41	123.33	28.96	31.77	0.93	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	175.80	35.84	12.94	11.45	1.91	0.42	0.21	0.00
ovary, adult, pool1	10020-101D2	156.80	44.29	14.06	17.03	0.52	0.44	0.35	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	432.82	109.08	33.00	36.48	0.92	0.18	0.37	0.18
pancreas, adult, donor1	10049-101G4	37.63	16.93	23.52	11.29	0.00	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	185.33	50.88	15.37	22.64	0.84	0.00	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	180.57	55.88	16.01	11.75	1.36	0.00	1.02	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	123.86	28.65	6.79	16.39	0.33	0.33	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	72.58	14.74	4.67	11.71	0.46	0.18	0.09	0.09
parietal cortex, adult, donor10258	10373-105G4	151.94	7.34	5.87	24.96	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	103.45	11.29	9.40	31.98	0.94	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	171.02	31.92	21.95	17.67	0.00	0.00	0.00	0.57
parietal lobe, adult, pool1	10034-101E7	91.56	16.57	7.05	13.13	0.26	0.09	0.00	0.09
parietal lobe, fetal, donor1	10072-101I9	21.34	6.79	6.79	15.52	0.00	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	93.46	20.94	8.22	19.07	0.00	2.24	0.00	0.00
parotid gland, adult	10199-103F1	102.98	37.62	36.38	17.88	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	252.98	75.73	29.54	17.72	2.15	0.54	2.15	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	14.87	5.02	0.74	6.69	0.00	0.56	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	265.60	87.27	45.17	36.57	1.02	1.02	0.44	0.73
pineal gland - adult, donor10196	10179-103C8	38.06	23.87	21.93	16.13	0.00	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	40.27	35.53	34.35	8.29	0.00	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	23.20	12.54	9.41	5.02	0.00	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	100.17	20.24	7.08	18.21	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	69.32	19.28	13.03	13.55	0.00	0.00	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	31.50	11.92	4.26	6.81	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	100.52	23.87	7.10	10.97	0.54	0.11	0.11	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	14.30	3.05	0.66	9.53	0.00	0.00	0.26	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	165.44	51.98	20.23	10.58	0.47	0.00	0.16	0.93
pons, adult, pool1	10033-101E6	16.87	6.71	2.75	3.36	0.17	0.34	0.00	0.00
postcentral gyrus, adult, pool1	10032-101E5	82.82	15.26	5.58	16.39	0.70	0.70	0.17	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	560.49	102.48	48.10	60.65	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	71.60	22.03	5.51	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	105.62	0.00	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	105.02	27.38	9.32	28.40	0.44	0.44	0.15	0.58
prostate cancer cell line:PC-3	10439-106E7	345.22	83.67	23.41	42.29	1.27	0.18	0.54	0.18
prostate, adult, pool1	10022-101D4	250.22	77.00	35.01	17.50	1.00	0.91	0.54	0.27
putamen, adult, donor10196	10176-103C5	195.22	16.29	5.43	55.95	0.24	0.71	0.00	0.24
putamen, adult, donor10252	10152-102I8	199.99	17.65	7.84	31.37	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	162.83	8.74	8.74	78.68	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	149.80	14.26	6.77	48.32	0.97	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	80.21	14.24	6.75	35.98	0.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	41.89	11.64	1.16	5.24	0.00	0.00	0.00	0.29
rectum, fetal, donor1	10067-101I4	319.93	66.77	57.03	43.12	1.39	1.39	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	59.36	21.41	7.42	8.06	0.21	0.00	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	17.81	6.63	0.83	7.46	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	55.56	37.18	26.04	5.86	0.40	1.99	0.20	0.00
retinoblastoma cell line:Y79	10475-106I7	17.15	16.89	9.35	7.27	0.00	0.00	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	36.52	17.58	5.78	7.87	0.00	0.25	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	30.93	14.90	5.06	5.06	0.00	1.41	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	388.02	139.45	75.79	29.56	1.52	5.30	2.27	0.00
salivary acinar cells, donor1	11771-123I7	172.05	35.45	33.02	13.60	0.81	0.16	0.32	0.65
salivary acinar cells, donor2	11772-123I8	95.42	24.10	15.01	11.15	0.55	0.14	0.14	0.00
salivary acinar cells, donor3	11773-123I9	168.82	41.05	29.13	15.23	0.00	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	84.08	20.02	28.60	13.15	1.14	0.57	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	108.51	31.20	10.71	20.91	0.84	1.10	0.17	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	114.26	26.68	10.11	22.10	0.24	0.47	0.59	0.35
seminal vesicle, adult	10201-103F3	224.33	102.11	41.27	16.40	1.06	0.53	0.53	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	103.73	32.07	16.52	8.50	0.97	0.49	0.00	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	108.45	35.73	20.89	12.08	0.75	0.25	0.25	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	129.46	39.14	16.06	21.07	3.01	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	31.70	12.76	4.84	3.09	0.13	0.13	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	139.26	47.42	14.81	12.93	0.55	0.44	0.00	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	27.48	15.61	8.90	2.45	0.39	0.00	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	35.47	10.64	4.26	3.55	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	41.62	12.11	3.96	5.88	0.36	0.00	0.00	0.12
skeletal muscle, fetal, donor1	10066-101I3	67.34	16.08	3.02	7.04	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	94.99	13.57	6.79	27.14	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	71.33	20.83	10.73	15.78	0.00	0.00	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	52.70	14.68	6.67	12.01	0.33	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	62.10	20.17	11.03	12.92	0.32	0.63	0.63	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	33.73	5.20	1.93	33.54	0.19	0.00	0.19	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	24.89	9.23	3.79	6.26	0.00	0.16	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	30.08	22.84	10.13	8.20	0.80	0.00	0.48	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	25.28	8.93	4.36	8.93	0.22	0.00	0.00	0.22
small intestine, adult, pool1	10024-101D6	114.19	33.92	12.66	7.17	1.31	0.12	0.48	0.12
small intestine, fetal, donor1	10064-101I1	128.50	32.92	16.71	17.20	0.74	0.74	0.49	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	29.24	6.67	7.69	2.56	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	614.61	213.48	139.57	27.14	2.33	3.10	1.55	0.52
somatostatinoma cell line:QGP-1	10781-110G7	53.34	19.30	12.06	15.01	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	72.03	37.62	14.68	7.57	0.00	0.23	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	71.76	26.02	7.10	4.73	0.39	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	17.99	6.92	3.46	5.53	0.00	0.69	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	27.44	14.64	5.49	5.49	0.61	0.00	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	41.33	14.69	9.18	2.76	0.00	0.00	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	670.75	158.17	95.59	34.05	1.05	0.60	0.60	0.90
spleen, adult, pool1	10025-101D7	113.00	25.33	11.45	12.56	0.22	0.44	0.33	0.11
spleen, fetal, pool1	10044-101F8	90.50	20.34	7.47	16.92	0.40	1.03	0.16	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	5.28	0.83	0.72	3.73	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	93.04	24.68	10.25	16.33	0.00	0.00	0.38	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	53.47	12.58	9.44	12.93	0.35	0.00	1.05	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	223.61	53.17	24.63	21.89	0.39	1.17	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	19.70	6.30	2.36	5.18	0.00	0.23	0.00	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	32.62	16.10	2.12	10.17	1.69	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	102.38	40.19	20.73	18.19	0.42	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	450.68	74.76	33.11	21.36	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	104.82	44.44	28.48	14.81	0.00	0.00	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	34.06	13.92	5.40	2.49	0.42	0.00	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	15.00	5.17	3.10	5.17	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	51.58	19.78	4.24	9.89	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	49.29	20.63	7.11	3.67	0.23	0.69	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	93.16	14.83	6.53	15.94	0.34	0.25	0.17	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	35.61	13.53	5.70	11.40	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	27.25	14.07	7.91	14.07	0.00	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	183.98	40.50	35.26	19.20	0.70	0.00	2.44	0.70
tenocyte, donor2	11765-123I1	68.67	22.13	18.31	7.63	0.00	3.05	0.00	0.38
tenocyte, donor3	11768-123I4	101.19	19.27	17.79	9.27	0.74	2.59	2.22	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	143.11	39.77	21.25	10.54	0.51	0.17	0.17	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	155.69	67.67	27.90	15.72	0.31	0.46	0.00	0.31
teratocarcinoma cell line:PA-1	10807-111A6	131.11	51.92	15.50	11.93	0.31	0.15	0.31	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	126.95	36.94	14.35	11.55	0.25	0.00	0.13	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	174.72	34.41	13.24	23.07	0.76	0.00	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	75.80	18.98	10.58	9.92	0.33	0.00	0.11	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	53.09	7.82	5.86	17.26	0.65	0.33	0.98	0.98
testis, adult, pool1	10026-101D8	92.02	25.66	10.52	11.38	0.43	1.50	0.21	0.11
testis, adult, pool2	10096-102C6	57.29	16.24	9.02	16.24	0.90	0.90	0.00	0.45
thalamus - adult, donor10196	10168-103B6	67.34	14.35	16.56	6.62	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	73.45	18.75	10.78	10.00	0.16	0.31	0.31	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	53.89	3.08	7.70	18.48	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	33.93	10.54	4.61	6.92	0.00	0.00	0.00	0.33
thalamus, newborn, donor10223	10366-105F6	60.98	32.79	11.51	8.05	0.00	0.00	0.00	0.00
throat, adult	10209-103G2	33.96	15.73	7.49	5.99	0.00	0.50	0.25	0.25
throat, fetal, donor1	10061-101H7	47.53	14.32	8.53	11.27	0.00	0.00	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	38.36	13.12	7.15	17.09	0.00	1.79	0.00	0.00
thymus, adult, pool1	10027-101D9	46.43	5.96	2.39	11.33	0.30	0.80	0.10	0.10
thymus, fetal, pool1	10043-101F7	63.28	8.62	4.47	14.55	0.31	1.35	0.10	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	372.42	105.57	35.63	35.23	2.13	0.13	1.20	1.06
thyroid carcinoma cell line:TCO-1	10783-110G9	264.02	53.92	24.31	30.31	0.14	0.00	0.42	0.56
thyroid, adult, pool1	10028-101E1	40.78	14.56	4.48	8.96	0.09	0.19	0.09	0.28
thyroid, fetal, donor1	10060-101H6	74.88	20.57	7.12	13.45	0.00	0.26	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	144.74	67.75	52.35	12.32	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	48.61	16.75	6.98	5.81	0.23	0.00	0.00	0.00
tongue, fetal, donor1	10059-101H5	39.02	9.85	5.12	10.25	0.00	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	65.11	20.44	8.31	10.02	0.20	0.50	0.10	0.00
trachea, adult, pool1	10029-101E2	120.90	32.47	12.43	13.33	0.08	0.98	0.08	0.16
trachea, fetal, donor1	10058-101H4	99.25	19.62	13.46	11.93	0.38	1.54	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	326.29	82.55	56.33	20.90	0.35	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	105.07	22.39	7.50	14.69	0.51	0.10	0.00	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	118.77	22.09	9.09	25.70	0.94	0.47	1.10	0.47
tridermal teratoma cell line:HGRT	10694-109G1	599.30	125.57	53.27	72.30	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	26.66	13.37	10.50	4.74	0.08	0.08	0.17	0.00
umbilical cord, fetal, donor1	10057-101H3	327.58	91.81	39.64	10.43	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	328.12	59.04	25.76	39.93	1.19	6.65	0.85	0.17
uterus, fetal, donor1	10055-101H1	285.14	51.19	28.67	27.64	0.51	2.56	0.51	0.00
vagina, adult	10204-103F6	211.31	109.85	60.74	16.15	1.29	0.65	1.29	0.00
vein, adult	10191-103E2	132.83	39.24	21.04	11.62	0.00	0.88	0.66	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	15.22	1.87	0.53	9.08	0.00	0.00	0.00	0.00